AI assistant
Amplifon — Interim / Quarterly Report 2023
Nov 9, 2023
4030_ir_2023-11-09_5b11b309-a7dc-4582-b71c-ccb5c8811886.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer



| PREFACE 4 |
|---|
| INTERIM MANAGEMENT REPORT AS AT 30 SEPTEMBER 2023 5 |
| HIGHLIGHTS 6 |
| MAIN ECONOMIC AND FINANCIAL FIGURES 7 |
| INDICATORS 8 |
| SHAREHOLDER INFORMATION 10 |
| RECLASSIFIED CONSOLIDATED INCOME STATEMENT 12 |
| RECLASSIFIED CONSOLIDATED BALANCE SHEET 15 |
| CONDENSED RECLASSIFIED CONSOLIDATED CASH FLOW STATEMENT 17 |
| INCOME STATEMENT REVIEW 18 |
| BALANCE SHEET REVIEW 35 |
| ACQUISITION OF COMPANIES AND BUSINESSES 47 |
| OUTLOOK 48 |
| CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS AS AT 30 SEPTEMBER 2023 50 |
| CONSOLIDATED STATEMENT OF FINANCIAL POSITION 51 |
| CONSOLIDATED INCOME STATEMENT 53 |
| STATEMENT OF CONSOLIDATED COMPREHENSIVE INCOME 54 |
| STATEMENT OF CHANGES IN CONSOLIDATED EQUITY 55 |
| STATEMENT OF CONSOLIDATED CASH FLOWS 57 |
| SUPPLEMENTARY INFORMATION TO THE STATEMENT OF CONSOLIDATED CASH FLOWS 58 |
| NOTES 59 |


| performance and financial position60 | |
|---|---|
| Acquisitions and goodwill | |
| Net financial position | |
| Lease liabilities | |
| Earnings (loss) per share | |
| Transactions with parents and other related parties | |
| Contingent liabilities | |
| Financial risk management | |
| Segment reporting | |
| Accounting policies | |
| 95 | |
| Consolidation scope | |
| Impact of the conflict in Ukraine, in Middle East, and climate change on the Group's 61 Intangible fixed assets with finite useful life64 Property, plant, and equipment65 Right-of-use assets66 Share capital67 68 Financial liabilities71 Provision for risk and charges74 75 Revenues from sales and services75 Operating costs, depreciation and impairment, financial income-expenses and taxes76 Performance Stock Grant77 Non-recurring significant events79 79 81 82 82 Translation of foreign companies' financial statements83 84 89 Subsequent events94 ANNEXES 95 |
Declaration of the Executive Responsible for Corporate Accounting Information pursuant to Article 154-bis of Legislative Decree 58/1998 (Consolidated finance act)....................................99
Disclaimer
This report contains forward looking statements ("Outlook") relating to future events and the Amplifon Group's operating, economic and financial results. These forecasts, by definition, contain elements of risk and uncertainty, insofar as they are linked to the occurrence of future events and developments. The actual results may be very different with respect to the original forecast due to several factors, the majority of which are out of the Group's control.


PREFACE
This Interim Financial Report as at 30 September 2023 was prepared in accordance with the International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board (IASB) endorsed by the European Union and should be read together with the Group's consolidated financial statements as at and for the year ended 31 December 2022 that includes additional information on the risks and uncertainties that could impact the Group's operating results or its financial position.

INTERIM MANAGEMENT REPORT
AS AT 30 SEPTEMBER 2023
HIGHLIGHTS
In the first nine months of 2023 Amplifon's turnover was higher compared to the comparison period thanks to above-market organic growth. Profitability, which was also higher than in the comparison period, was impacted by decreased operating leverage in EMEA due to the significant investments made to support future growth in a market that was weaker than expected.
| (€ thousands) | First nine months 2023 | First nine months 2022 | |||
|---|---|---|---|---|---|
| Recurring | Total | Recurring | Total | ||
| Economic figures: | |||||
| Revenues from sales and services | 1,645,065 | 1,645,065 | 1,539,695 | 1,539,695 | |
| Gross operating profit (loss) (EBITDA) | 385,806 | 372,585 | 369,530 | 363,849 | |
| Operating profit (loss) (EBIT) | 192,890 | 179,669 | 191,252 | 185,571 | |
| Profit (loss) before tax | 155,996 | 142,775 | 165,680 | 159,999 | |
| Group net profit (loss) | 112,815 | 103,438 | 119,577 | 115,484 |
The first nine months of the year closed with:
- turnover of €1,645,065 thousand, an increase of 6.8% compared to the same period of the prior year (+9.7% at constant exchange rates).
- a recurring gross operating margin (EBITDA) of €385,806 thousand, 4.4% higher than in the first nine months of 2022, with an EBITDA margin of 23.5% (-0.5 p.p. against the comparison period).
- recurring Group net profit of €112,815 thousand, a decrease of €6,762 thousand (-5.7%) compared to first nine months of 2022, due to higher amortization, depreciation and financial expenses.
Net financial debt, without lease liabilities, amounts to €917,633 thousand compared to €829,993 thousand at year-end 2022. Free cash flow reached a positive €68,772 thousand (compared to € 142,968 thousand in the first nine months of the prior year) after higher capital expenditure (€99,833 thousand versus €75,363 thousand in the comparison period), greater absorption of working capital (the comparison period benefitted significantly from the renegotiation and extension of payment terms with suppliers) and higher tax payments. Cashouts for acquisitions, which amounted to €83,243 thousand (€52,243 thousand in the first nine months of 2022), along with the payment of €65,361 thousand in dividends (€58,237 thousand in the comparison period) and costs related to other financial assets of €3,878 thousand, bring cash flow for the reporting period to negative €83,847 thousand versus a negative €10,088 thousand in the first nine months of 2022.
MAIN ECONOMIC AND FINANCIAL FIGURES
| (€ thousands) | First nine months 2023 | First nine months 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Recurring | Non recurring |
Total | % on revenues recurring |
Recurring | Non recurring |
Total | % on revenues recurring |
Change % on recurring |
|
| Economic figures: | |||||||||
| Revenues from sales and services |
1,645,065 | - | 1,645,065 | 100.0% | 1,539,695 | - | 1,539,695 | 100.0% | 6.8% |
| Gross operating profit (loss) (EBITDA) |
385,806 | (13,221) | 372,585 | 23.5% | 369,530 | (5,681) | 363,849 | 24.0% | 4.4% |
| Operating profit (loss) before the depreciation and amortization of PPA related assets (EBITA) |
229,538 | (13,221) | 216,317 | 14.0% | 226,447 | (5,681) | 220,766 | 14.7% | 1.4% |
| Operating profit (loss) (EBIT) |
192,890 | (13,221) | 179,669 | 11.7% | 191,252 | (5,681) | 185,571 | 12.4% | 0.9% |
| Profit (loss) before tax | 155,996 | (13,221) | 142,775 | 9.5% | 165,680 | (5,681) | 159,999 | 10.8% | -5.8% |
| Group net profit (loss) | 112,815 | (9,377) | 103,438 | 6.9% | 119,577 | (4,093) | 115,484 | 7.8% | -5.7% |
| (€ thousands) | 09/30/2023 | 12/31/2022 | Change | ||||||
| Financial figures: | |||||||||
| Non-current assets | 2,956,863 | 2,874,982 | 81,881 | ||||||
| Net invested capital | 2,475,983 | 2,338,949 | 137,034 | ||||||
| Group net equity | 1,069,770 | 1,038,509 | 31,261 | ||||||
| Total net equity | 1,070,715 | 1,040,350 | 30,365 | ||||||
| Net financial indebtedness | 917,633 | 829,993 | 87,640 19,029 |
||||||
| Lease liabilities | 487,635 | 468,606 | |||||||
| Total lease liabilities and net financial indebtedness | 1,405,268 | 1,298,599 | 106,669 | ||||||
| (€ thousands) | First nine months 2023 | First nine months 2022 | |||||||
| Free cash flow | 68,772 | 142,968 | |||||||
| Cash flow generated from (absorbed by) business combinations | (83,243) | (52,243) | |||||||
| Cash flow provided by (used in) financing activities | (69,376) | (100,813) | |||||||
| Net cash flow from the period | (83,847) | (10,088) | |||||||
| Effect of exchange rate fluctuations on the net financial position | (3,793) | (791) | |||||||
| Net cash flow from the period with changes for exchange rate fluctuations | (87,640) | (10,879) |
- EBITDA is the operating result before charging amortization, depreciation, impairment of both tangible and intangible fixed assets and the right of use depreciation.
- EBITA is the operating result before amortization and impairment of customer lists, trademarks, non-competition agreements and other fixed assets arising from business combinations.
- EBIT is the operating result before financial income and charges and taxes.

- Free cash flow represents the cash flow of operating and investing activities before the cash flows used in acquisitions and payment of dividends and the cash flows from or used in other financing activities.
INDICATORS
| 09/30/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|
| Net financial indebtedness (€ thousands) | 917,633 | 829,993 | 882,065 |
| Lease liabilities (€ thousands) | 487,635 | 468,606 | 471,537 |
| Total lease liabilities & net financial indebtedness (€ thousands) | 1,405,268 | 1,298,599 | 1,353,602 |
| Net equity (€ thousands) | 1,070,715 | 1,040,350 | 1,025,438 |
| Group Net Equity (€ thousands) | 1,069,770 | 1,038,509 | 1,023,171 |
| Net financial indebtedness/Net Equity | 0.86 | 0.80 | 0.86 |
| Net financial indebtedness/Group Net Equity | 0.86 | 0.80 | 0.86 |
| Net financial indebtedness/EBITDA | 1.63 | 1.52 | 1.61 |
| EBITDA/Net financial expenses | 21.58 | 22.26 | 28.09 |
| Earnings per share (EPS) (€) | 0.46167 | 0.79570 | 0.51488 |
| Diluted EPS (€) | 0.45805 | 0.78699 | 0.50906 |
| EPS (€) adjusted for non-recurring transactions and amortization/depreciation related to purchase price allocations to tangible and intangible assets |
0.63150 | 0.97738 | 0.65024 |
| Group Net Equity per share (€) | 4.744 | 4.625 | 4.554 |
| Period-end price (€) | 28.12 | 27.82 | 26.90 |
| Highest price in period (€) | 36.27 | 47.04 | 47.43 |
| Lowest price in period (€) | 25.02 | 23.25 | 24.17 |
| Share price/net equity per share | 5.928 | 6.016 | 5.906 |
| Market capitalization (€ millions) | 6,341.36 | 6,247.18 | 6,044.30 |
| Number of shares outstanding | 225,510,487 | 224,557,260 | 224,695,315 |
- Net financial indebtedness/net equity is the ratio of net financial indebtedness, excluding lease liabilities and short-term investments not cash equivalents, to total net equity.
- Net financial indebtedness/Group net equity is the ratio of net financial indebtedness, excluding lease liabilities and short-term investments not cash equivalents, to the Group's net equity.
- Net financial indebtedness/EBITDA is the ratio of net financial indebtedness, excluding lease liabilities and short-term investments not cash equivalents, to EBITDA for the last four quarters (determined with reference to recurring operations only, based on pro forma figures in case of significant changes to the structure of the Group).
- EBITDA/net financial expenses ratio is the ratio of EBITDA for the last four quarters (determined with reference to recurring operations only, based on restated figures in case of significant changes to the structure of the Group) to net interest payable and receivable of the same last four quarters.
- Earnings per share (EPS) (€) is the net profit for the period attributable to the parent's ordinary shareholders divided by the weighted average number of shares outstanding during


the period, considering purchases and sales of treasury shares as cancellations or issues of shares, respectively.
- Diluted earnings per share (EPS) (€) is the net profit for the period attributable to the parent's ordinary shareholders divided by the weighted average number of shares outstanding during the period adjusted for the dilution effect of potential shares. In the calculation of outstanding shares, purchases and sales of treasury shares are considered as cancellations and issues of shares, respectively.
- Earnings per share (EPS) adjusted for non-recurring transactions and amortization/depreciation related to purchase price allocations to tangible and intangible assets (€) is the profit for the period from recurring operations attributable to the parent's ordinary shareholders divided by the weighted average number of outstanding shares in the period adjusted to reflect the amortization of purchase price allocations. When calculating the number of outstanding shares, the purchases and sales of treasury shares are considered cancellations and share issues, respectively.
- Net Equity per share (€) is the ratio of Group equity to the number of outstanding shares.
- Period-end price (€) is the closing price on the last stock exchange trading day of the period.
- Highest price (€) and lowest price (€) are the highest and lowest prices from 1 January to the end of the period.
- Share price/Net equity per share is the ratio of the share closing price on the last stock exchange trading day of the period to net equity per share.
- Market capitalization is the closing price on the last stock exchange trading day of the period multiplied by the number of outstanding shares.
- The number of shares outstanding is the number of shares issued less treasury shares.

SHAREHOLDER INFORMATION
Main shareholders
The main Shareholders of Amplifon S.p.A. as at 30 September 2023 are:
Ampliter S.r.l. Treasury shares Market

| Shareholder | No. of ordinary shares (*) |
% held | % of the total share capital in voting rights |
|---|---|---|---|
| Ampliter S.r.l. | 95,344,369 | 42.12% | 59.16% |
| Treasury shares | 878,133 | 0.39% | 0.28% |
| Market | 130,166,118 | 57.49% | 40.56% |
| Total | 226,388,620 | 100.0% | 100.0% |
(*) Number of shares related to the share capital registered with the Company registrar on 30 September 2023.
Pursuant to article 2497 of the Italian Civil Code, Amplifon S.p.A. is not subject to management and coordination either by its direct parent Ampliter S.r.l. or its indirect parent.
The shares of the parent Amplifon S.p.A. have been listed on the screen-based stock market Euronext Milano (EXM) since 27 June 2001 and since 10 September 2008 in the STAR segment. Amplifon is also included in the FTSE MIB index and in the Stoxx Europe 600 index.
The chart shows the performance of the Amplifon share price and its trading volumes from 30 December 2022, last trading day of the year, to 29 September 2023, last trading day of third quarter.


As at 30 September 2023 market capitalization was €6,341 million.
Dealings in Amplifon shares in the screen-based stock market Euronext Milano (EXM) during the period 30 December 2022 – 29 September 2023, showed:
- average daily value: €19,421,668.48;
- average daily volume: €633,439.21 shares;
- total volume traded of 123,520,646 shares, or 54.77% of the total number of shares comprising the share capital, net of treasury shares.

RECLASSIFIED CONSOLIDATED INCOME STATEMENT
| (€ thousands) | First nine months 2023 | First nine months 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Recurring | Non recurring (*) |
Total | % on recurring |
Recurring | Non recurring (*) |
Total | % on recurring |
Change % on recurring |
|
| Revenues from sales and services |
1,645,065 | - | 1,645,065 | 100.0% | 1,539,695 | - | 1,539,695 | 100.0% | 6.8% |
| Operating costs | (1,263,004) | (13,221) | (1,276,225) | -76.7% | (1,175,114) | (5,630) | (1,180,744) | -76.3% | -7.5% |
| Other income and costs | 3,745 | - | 3,745 | 0.2% | 4,949 | (51) | 4,898 | 0.3% | -24.3% |
| Gross operating profit (loss) (EBITDA) |
385,806 | (13,221) | 372,585 | 23.5% | 369,530 | (5,681) | 363,849 | 24.0% | 4.4% |
| Depreciation, amortization and impairment losses on non-current assets |
(68,360) | - | (68,360) | -4.2% | (62,026) | - | (62,026) | -4.0% | -10.2% |
| Right-of-use depreciation | (87,908) | - | (87,908) | -5.3% | (81,057) | - | (81,057) | -5.3% | -8.5% |
| Operating result before the amortization and impairment of PPA related assets (EBITA) |
229,538 | (13,221) | 216,317 | 14.0% | 226,447 | (5,681) | 220,766 | 14.7% | 1.4% |
| PPA related depreciation, amortization and impairment |
(36,648) | - | (36,648) | -2.3% | (35,195) | - | (35,195) | -2.3% | -4.1% |
| Operating profit (loss) (EBIT) | 192,890 | (13,221) | 179,669 | 11.7% | 191,252 | (5,681) | 185,571 | 12.4% | 0.9% |
| Income, expenses, valuation and adjustments of financial assets |
210 | - | 210 | 0.0% | 323 | - | 323 | 0.0% | -35.0% |
| Net financial expenses | (33,410) | - | (33,410) | -2.0% | (23,983) | - | (23,983) | -1.6% | -39.3% |
| Exchange differences, inflation accounting and Fair Value valuation |
(3,693) | - | (3,693) | -0.2% | (1,912) | - | (1,912) | 0.0% | -93.2% |
| Profit (loss) before tax | 155,997 | (13,221) | 142,776 | 9.5% | 165,680 | (5,681) | 159,999 | 10.8% | -5.8% |
| Tax | (43,179) | 3,844 | (39,335) | -2.6% | (45,877) | 1,588 | (44,289) | -3.0% | 5.9% |
| Profit (loss) from continuing operations |
112,818 | (9,377) | 103,441 | 6.9% | 119,803 | (4,093) | 115,710 | 7.8% | -5.8% |
| Profit (loss) from discontinued operations |
3 | - | 3 | 0.0% | 226 | - | 226 | 0.0% | -98.7% |
| Net profit (loss) | 112,815 | (9,377) | 103,438 | 6.9% | 119,577 | (4,093) | 115,484 | 7.8% | -5.7% |
(*) See table at page 14 for details of non-recurring transactions.

Interim Financial Report as at 30 September 2023 > Interim Management Report
| (€ thousands) | Third Quarter 2023 | Third Quarter 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Recurring | Non recurring (*) |
Total | % on recurring |
Recurring | Non recurring (*) |
Total | % on recurring |
Change % on recurring |
|
| Revenues from sales and services |
531,296 | - | 531,296 | 100.0% | 502,489 | - | 502,489 | 100.0% | 5.8% |
| Operating costs | (421,266) | (1,937) | (423,203) | -79.3% | (394,350) | (652) | (395,002) | -78.5% | -6.8% |
| Other income and costs | (265) | - | (265) | 0.0% | 1,275 | - | 1,275 | 0.3% | -120.8% |
| Gross operating profit (loss) (EBITDA) |
109,765 | (1,937) | 107,828 | 20.7% | 109,414 | (652) | 108,762 | 21.8% | 0.3% |
| Depreciation, amortization and impairment losses on non-current assets |
(23,010) | - | (23,010) | -4.3% | (21,015) | - | (21,015) | -4.2% | -9.5% |
| Right-of-use depreciation | (29,233) | - | (29,233) | -5.6% | (27,383) | - | (27,383) | -5.4% | -6.8% |
| Operating result before the amortization and impairment of PPA related assets (EBITA) |
57,522 | (1,937) | 55,585 | 10.8% | 61,016 | (652) | 60,364 | 12.2% | -5.7% |
| PPA related depreciation, amortization and impairment |
(12,132) | - | (12,132) | -2.3% | (11,960) | - | (11,960) | -2.4% | -1.4% |
| Operating profit (loss) (EBIT) | 45,390 | (1,937) | 43,453 | 8.5% | 49,056 | (652) | 48,404 | 9.8% | -7.5% |
| Income, expenses, valuation and adjustments of financial assets |
3 | - | 3 | 0.0% | 56 | - | 56 | 0.0% | -94.6% |
| Net financial expenses (**) | (13,568) | - | (13,568) | -2.6% | (8,148) | - | (8,148) | -1.5% | -66.5% |
| Exchange differences, inflation accounting and Fair Value valuation (**) |
389 | - | 389 | 0.2% | (180) | - | (180) | -0.1% | 316.1% |
| Profit (loss) before tax | 32,214 | (1,937) | 30,277 | 6.1% | 40,784 | (652) | 40,132 | 8.2% | -21.0% |
| Tax | (8,708) | 548 | (8,160) | -1.7% | (11,061) | 177 | (10,884) | -2.3% | 21.3% |
| Profit (loss) from continuing operations |
23,506 | (1,389) | 22,117 | 4.4% | 29,723 | (475) | 29,248 | 5.9% | -20.9% |
| Profit (loss) from discontinued operations |
35 | - | 35 | 0.0% | 44 | - | 44 | 0.0% | -20.5% |
| Net profit (loss) | 23,471 | (1,389) | 22,082 | 4.4% | 29,679 | (475) | 29,204 | 5.9% | -20.9% |
(*) See table at page 14 for details of non-recurring transactions.
(**) It is specified that, on the 2022 comparative period, reclassifications between income, expenses and adjustments of financial assets have been made in order to better represent financial information.


The non-recurring transactions, included in the previous tables, are summarized below:
- on 5 January 2023 the majority shareholder Ampliter S.r.l. ("Ampliter") issued a plan which provides for the one-off assignment, free of charge, of up to a maximum of 500,000 of the Amplifon shares owned by Ampliter, to the Chief Executive Officer.
The shares will be transferred, free of charge, in five tranches, comprising a first tranche of 260,000 shares and subsequent ones of 60,000 shares each.
As a result of this assignment, which was made completely autonomously by Ampliter and does not envisage any cash-out by Amplifon, based on IFRS 2 "Share Based Payments" an estimated one-off notional cost of €13.7 million was recognized in the income statement, of which €12.4 million in 2023 and €1.3 million in 2024.
The notional cost for the first nine months (€11,614 thousand) was recognized as a nonrecurring expense at 30 September 2023.
- €1,433 thousand were spent on the second phase of the GAES integration in Spain.
- €174 thousand were also spent on the Bay Audio integration in Australia.
| First nine months |
First nine months |
|
|---|---|---|
| (€ thousand) | 2023 | 2022 |
| Notional cost related to share assignment | (11,614) | - |
| Bay Audio acquisition and integration costs | (174) | (2,655) |
| GAES second phase integration costs | (1,433) | (2,026) |
| Charitable donation costs | - | (1,000) |
| Impact of the non-recurring items on EBITDA | (13,221) | (5,681) |
| Impact of the non-recurring items on EBIT | (13,221) | (5,681) |
| Impact of the non-recurring items on profit before tax | (13,221) | (5,681) |
| Impact of the above items on the tax burden for the period | 3,844 | 1,588 |
| Impact of the non-recurring items on net profit | (9,377) | (4,093) |
| (€ thousand) | Q3 2023 | Q3 2022 |
| Notional cost related to share assignment | (1,220) | - |
| Bay Audio acquisition and integration costs | (174) | (308) |
| GAES second phase integration costs | (543) | (344) |
| Charitable donation costs | - | - |
| Impact of the non-recurring items on EBITDA | (1,937) | (652) |
| Impact of the non-recurring items on EBIT | (1,937) | (652) |
| Impact of the non-recurring items on profit before tax | (1,937) | (652) |
| Impact of the above items on the tax burden for the period | 548 | 177 |
| Impact of the non-recurring items on net profit | (1,389) | (475) |

RECLASSIFIED CONSOLIDATED BALANCE SHEET
The reclassified Consolidated Balance Sheet aggregates assets and liabilities according to operating functionality criteria, subdivided by convention into the following three key functions: investments, operations and finance.
| (€ thousands) | 09/30/2023 | 12/31/2022 | Change |
|---|---|---|---|
| Goodwill | 1,794,323 | 1,754,028 | 40,295 |
| Customer lists, non-compete agreements, trademarks and location rights | 260,392 | 266,125 | (5,733) |
| Software, licenses, other int.ass., wip and advances | 164,772 | 153,973 | 10,799 |
| Property, plant, and equipment | 207,697 | 193,415 | 14,282 |
| Right of use assets | 468,226 | 451,747 | 16,479 |
| Fixed financial assets (1) | 16,108 | 13,292 | 2,816 |
| Other non-current financial assets (1) | 45,345 | 42,402 | 2,943 |
| Total fixed assets | 2,956,863 | 2,874,982 | 81,881 |
| Inventories | 84,712 | 76,258 | 8,454 |
| Trade receivables | 202,889 | 192,066 | 10,823 |
| Other receivables | 108,219 | 77,891 | 30,328 |
| Current assets (A) | 395,820 | 346,215 | 49,605 |
| Total assets | 3,352,683 | 3,221,197 | 131,486 |
| Trade payables | (324,454) | (325,583) | 1,129 |
| Other payables (2) | (346,019) | (360,461) | 14,442 |
| Provisions for risks (current portion) | (975) | (1,663) | 688 |
| Short term liabilities (B) | (671,448) | (687,707) | 16,259 |
| Net working capital (A) - (B) | (275,628) | (341,492) | 65,864 |
| Derivative instruments (3) | 19,429 | 24,474 | (5,045) |
| Deferred tax assets | 88,193 | 81,780 | 6,413 |
| Deferred tax liabilities | (105,897) | (106,683) | 786 |
| Provisions for risks (non-current portion) | (19,511) | (19,944) | 433 |
| Employee benefits (non-current portion) | (10,099) | (8,940) | (1,159) |
| Loan fees (4) | 3,448 | 4,508 | (1,060) |
| Other long-term payables | (180,815) | (169,736) | (11,079) |
| NET INVESTED CAPITAL | 2,475,983 | 2,338,949 | 137,034 |
| Shareholders' equity | 1,069,770 | 1,038,509 | 31,261 |
| Third parties' equity | 945 | 1,841 | (896) |
| Net equity | 1,070,715 | 1,040,350 | 30,365 |
| Long term net financial debt (4) | 665,982 | 807,907 | (141,925) |
| Short term net financial debt (4) | 251,651 | 22,086 | 229,565 |
| Total net financial debt | 917,633 | 829,993 | 87,640 |
| Lease liabilities | 487,635 | 468,606 | 19,029 |
| Total lease liabilities & net financial debt | 1,405,268 | 1,298,599 | 106,669 |
| NET EQUITY, LEASE LIABILITIES AND NET FINANCIAL DEBT | 2,475,983 | 2,338,949 | 137,034 |


Notes for reconciling the condensed balance sheet with the statutory balance sheet:
- (1) "Financial fixed assets" and "Other non-current financial assets" include equity interests valued by using the net equity method, financial assets at fair value through profit and loss and other non-current assets;
- (2) "Other payables" includes other liabilities, accrued liabilities and deferred income, current portion of liabilities for employees' benefits and tax liabilities;
- (3) "Derivatives instruments" includes cash flow hedging instruments not included in the item "Net medium and long-term financial indebtedness";
- (4) The item "loan fees" is presented in the balance sheet as a direct reduction of the short-term and medium/longterm components of the items "financial payables" and "financial liabilities" for the short-term and long-term portions, respectively.

CONDENSED RECLASSIFIED CONSOLIDATED CASH FLOW STATEMENT
The condensed consolidated cash flow statement is a summarized version of the reclassified statement of cash flows set out in the following pages and its purpose is, starting from the EBIT, to detail the cash flows from or used in operating, investing and financing activities.
| (€ thousands) | First nine months 2023 | First nine months 2022 |
|---|---|---|
| EBIT | 179,669 | 185,571 |
| Amortization, depreciation and write-downs | 192,916 | 178,278 |
| Provisions, other non-monetary items and gain/losses from disposals | 28,735 | 15,826 |
| Net financial expenses | (33,971) | (22,842) |
| Taxes paid | (60,679) | (33,048) |
| Changes in net working capital | (52,970) | (25,329) |
| Cash flow provided by (used in) operating activities before repayment of lease liabilities |
253,700 | 298,456 |
| Repayment of lease liabilities | (85,095) | (80,125) |
| Cash flow provided by (used in) operating activities (A) | 168,605 | 218,331 |
| Cash flow provided by (used in) operating investing activities (B) | (99,833) | (75,363) |
| Free Cash Flow (A) + (B) | 68,772 | 142,968 |
| Net cash flow provided by (used in) acquisitions (C) | (83,243) | (52,243) |
| Cash flow provided by (used in) investing activities (B+C+D) | (183,076) | (127,606) |
| Cash flow provided by (used in) operating activities and investing activities | (14,471) | 90,725 |
| Dividends | (65,361) | (58,237) |
| Treasury Shares | - | (42,872) |
| Capital increases, third parties' contributions and dividends paid by subsidiaries to third parties |
(137) | (608) |
| Hedging instruments | (1,483) | - |
| Fees paid on medium/long term financing | (1,413) | - |
| Change in non-current assets | (982) (982) |
904 |
| Net cash flow from the period | (83,847) | (10,088) |
| Net financial indebtedness at the beginning of the period | (829,993) | (871,186) |
| Effect of exchange rate fluctuations on net financial indebtedness | (3,793) | (791) |
| Changes in net indebtedness | (83,847) | (10,088) |
| Net financial indebtedness at the end of the period | (917,633) | (882,065) |
The impact of non-recurring transactions on free cash flow in the period is shown in the following table.
| (€ thousands) | First nine months 2023 | First nine months 2022 |
|---|---|---|
| Free cash flow | 68,772 | 142,968 |
| Free cash flow generated by non-recurring transactions (see page 46 for details) | (2,740) | (4,629) |
| Free cash flow generated by recurring transactions | 71,512 | 147,597 |
INCOME STATEMENT REVIEW
Consolidated income statement by segment and geographic area
| (€ thousands) | First nine months 2023 | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 1,067,232 | 321,984 | 255,511 | 338 | 1,645,065 |
| Operating costs | (771,871) | (237,908) | (189,209) | (77,237) | (1,276,225) |
| Other income and costs | 3,473 | (127) | (10) | 409 | 3,745 |
| Gross operating profit (loss) (EBITDA) | 298,834 | 83,949 | 66,292 | (76,490) | 372,585 |
| Depreciation, amortization and impairment of non-current assets |
(30,769) | (8,919) | (10,329) | (18,343) | (68,360) |
| Right-of-use depreciation | (58,042) | (8,675) | (19,491) | (1,700) | (87,908) |
| Operating profit (loss) before the depreciation and amortization of PPA related assets (EBITA) |
210,023 | 66,355 | 36,472 | (96,533) | 216,317 |
| PPA related depreciation, amortization and impairment |
(24,733) | (3,135) | (8,738) | (42) | (36,648) |
| Operating profit (loss) (EBIT) | 185,290 | 63,220 | 27,734 | (96,575) | 179,669 |
| Income, expenses, revaluation and adjustments of financial assets |
210 | ||||
| Net financial expenses | (33,410) | ||||
| Exchange differences, inflation accounting and Fair Value valuation |
(3,693) | ||||
| Profit (loss) before tax | 142,776 | ||||
| Tax | (39,335) | ||||
| Net profit (loss) | 103,441 | ||||
| Profit (loss) of minority interests | 3 | ||||
| Net profit (loss) attributable to the Group | 103,438 |
| (€ thousands) | First nine months 2023 - Only recurring operations | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 1,067,232 | 321,984 | 255,511 | 338 | 1,645,065 |
| Gross operating profit (loss) (EBITDA) | 300,267 | 83,949 | 66,465 | (64,875) | 385,806 |
| Operating profit (loss) before the depreciation and amortization of PPA related assets (EBITA) |
211,457 | 66,351 | 36,643 | (84,917) | 229,534 |
| Operating profit (loss) (EBIT) | 186,723 | 63,220 | 27,907 | (84,960) | 192,890 |
| Profit (loss) before tax | 155,997 | ||||
| Net profit (loss) | 112,818 | ||||
| Net profit (loss) attributable to the Group | 112,815 |
| (€ thousands) | First nine months 2022 | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 1,019,254 | 282,043 | 237,986 | 412 | 1,539,695 |
| Operating costs | (734,181) | (207,547) | (178,175) | (60,841) | (1,180,744) |
| Other income and costs | 4,774 | (1,040) | 205 | 959 | 4,898 |
| Gross operating profit (loss) (EBITDA) | 289,847 | 73,456 | 60,016 | (59,470) | 363,849 |
| Depreciation, amortization and impairment of non-current assets |
(30,017) | (8,426) | (9,590) | (13,993) | (62,026) |
| Right-of-use depreciation | (56,187) | (5,791) | (17,378) | (1,701) | (81,057) |
| Operating profit (loss) before the depreciation and amortization of PPA related assets (EBITA) |
203,643 | 59,239 | 33,048 | (75,164) | 220,766 |
| PPA related depreciation, amortization and impairment |
(23,286) | (2,613) | (9,235) | (61) | (35,195) |
| Operating profit (loss) (EBIT) | 180,357 | 56,626 | 23,813 | (75,225) | 185,571 |
| Income, expenses, revaluation and adjustments of financial assets |
323 | ||||
| Net financial expenses | (23,983) | ||||
| Exchange differences, inflation accounting and Fair Value valuation |
(1,912) | ||||
| Profit (loss) before tax | 159,999 | ||||
| Tax | (44,289) | ||||
| Net profit (loss) | 115,710 | ||||
| Profit (loss) of minority interests | 226 | ||||
| Net profit (loss) attributable to the Group | 115,484 |
| (€ thousands) | First nine months 2022 – Only recurring operations | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 1,019,254 | 282,043 | 237,986 | 412 | 1,539,695 |
| Gross operating profit (loss) (EBITDA) | 291,873 | 73,456 | 62,671 | (58,470) | 369,530 |
| Operating profit (loss) before the depreciation and amortization of PPA related assets (EBITA) |
205,669 | 59,240 | 35,702 | (74,164) | 226,447 |
| Operating profit (loss) (EBIT) | 182,383 | 56,626 | 26,468 | (74,225) | 191,252 |
| Profit (loss) before tax | 165,680 | ||||
| Net profit (loss) | 119,803 | ||||
| Net profit (loss) attributable to the Group | 119,577 |

| (€ thousands) | Third Quarter 2023 | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 331,750 | 109,323 | 90,130 | 93 | 531,296 |
| Operating costs | (250,125) | (81,558) | (66,435) | (25,085) | (423,203) |
| Other income and costs | 720 | (920) | (25) | (40) | (265) |
| Gross operating profit (loss) (EBITDA) | 82,345 | 26,845 | 23,670 | (25,032) | 107,828 |
| Depreciation, amortization and impairment of non-current assets |
(10,486) | (2,859) | (3,130) | (6,535) | (23,010) |
| Right-of-use depreciation | (19,368) | (3,285) | (6,012) | (568) | (29,233) |
| Operating profit (loss) before the depreciation and amortization of PPA related assets (EBITA) |
52,491 | 20,701 | 14,528 | (32,135) | 55,585 |
| PPA related depreciation, amortization and impairment |
(8,418) | (873) | (2,841) | - | (12,132) |
| Operating profit (loss) (EBIT) | 44,073 | 19,828 | 11,687 | (32,135) | 43,453 |
| Income, expenses, revaluation and adjustments of financial assets |
3 | ||||
| Net financial expenses | (13,568) | ||||
| Exchange differences, inflation accounting and Fair Value valuation |
389 | ||||
| Profit (loss) before tax | 30,277 | ||||
| Tax | (8,160) | ||||
| Profit (loss) from continuing operations | 22,117 | ||||
| Profit (loss) from discontinued operations | 35 | ||||
| Net profit (loss) | 22,082 |
| (€ thousands) | Third Quarter 2023 – Only Recurring operations | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 331,750 | 109,323 | 90,130 | 93 | 531,296 |
| Gross operating profit (loss) (EBITDA) | 82,889 | 26,845 | 23,843 | (23,812) | 109,765 |
| Operating profit (loss) before the depreciation and amortization of PPA related assets (EBITA) |
53,035 | 20,701 | 14,701 | (30,915) | 57,522 |
| Operating profit (loss) (EBIT) | 44,617 | 19,828 | 11,860 | (30,915) | 45,390 |
| Profit (loss) before tax | 32,214 | ||||
| Net profit (loss) | 23,506 | ||||
| Net profit (loss) attributable to the Group | 23,471 |

| (€ thousands) | Third Quarter 2022 | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | |
| Revenues from sales and services | 314,605 | 101,254 | 86,493 | 137 | 502,489 |
| Operating costs | (234,509) | (75,863) | (64,011) | (20,619) | (395,002) |
| Other income and costs | 1,580 | (481) | 13 | 163 | 1,275 |
| Gross operating profit (loss) (EBITDA) | 81,676 | 24,910 | 22,495 | (20,319) | 108,762 |
| Depreciation, amortization and impairment of non-current assets |
(10,148) | (2,970) | (3,007) | (4,890) | (21,015) |
| Right-of-use depreciation | (18,640) | (2,075) | (6,098) | (570) | (27,383) |
| Operating profit (loss) before the depreciation and amortization of PPA related assets (EBITA) |
52,888 | 19,865 | 13,390 | (25,779) | 60,364 |
| PPA related depreciation, amortization and impairment |
(7,821) | (981) | (3,138) | (20) | (11,960) |
| Operating profit (loss) (EBIT) | 45,067 | 18,884 | 10,252 | (25,799) | 48,404 |
| Income, expenses, revaluation and adjustments of financial assets |
56 | ||||
| Net financial expenses (**) | (8,148) | ||||
| Exchange differences, inflation accounting and Fair Value valuation (**) |
(180) | ||||
| Profit (loss) before tax | 40,132 | ||||
| Tax | (10,884) | ||||
| Profit (loss) from continuing operations | 29,248 | ||||
| Profit (loss) from discontinued operations | 44 | ||||
| Net profit (loss) | 29,204 |
(**) It is specified that, on the 2022 comparative period, reclassifications between income, expenses and adjustments of financial assets have been made in order to better represent financial information.
| (€ thousands) | Third Quarter 2022 – Only recurring operations | |||||
|---|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Corporate | Total | ||
| Revenues from sales and services | 314,605 | 101,254 | 86,493 | 137 | 502,489 | |
| Gross operating profit (loss) (EBITDA) | 82,020 | 24,910 | 22,803 | (20,319) | 109,414 | |
| Operating profit (loss) before the depreciation and amortization of PPA related assets (EBITA) |
53,232 | 19,864 | 13,698 | (25,778) | 61,016 | |
| Operating profit (loss) (EBIT) | 45,411 | 18,884 | 10,560 | (25,799) | 49,056 | |
| Profit (loss) before tax | 40,784 | |||||
| Net profit (loss) | 29,723 | |||||
| Net profit (loss) attributable to the Group | 29,679 |

Revenues from sales and services
| (€ thousands) | First nine months 2023 | First nine months 2022 | Change | Change % |
|---|---|---|---|---|
| Revenues from sales and services |
1,645,065 | 1,539,695 | 105,370 | 6.8% |
| (€ thousands) | Third quarter 2023 | Third quarter 2022 | Change | Change % |
| Revenues from sales and services |
531,295 | 502,489 | 28,806 | 5.7% |
Consolidated revenues from sales and services amounted to €1,645,065 thousand in the first nine months of 2023, an increase of €105,370 thousand (+6.8%) with respect to the comparison period.
The increase against the first nine months of 2022 is explained for €117,623 thousand (+7.6%) by organic growth and for €32,871 thousand (+2.1%) by acquisitions. The foreign exchange effect was negative for €45,124 thousand (-2.9%).
The performance was very positive across all geographic areas: a strong performance in revenues was reported in EMEA despite a softer than expected market and one less working day than in the comparison period; AMERICAS posted the highest growth in revenues, driven by both an excellent organic growth and acquisitions; APAC also recorded an excellent performance, boosted by double-digit organic growth in all the area's markets and the recent acquisitions in China.
In the third quarter alone consolidated revenues from sales and services amounted to € 531,295 thousand, an increase of €28,806 thousand (+5.7%) compared to the third quarter of 2022 explained, for €45,213 thousand (+9.0%), by positive organic growth and, for 11,921 thousand (+2.4%) by acquisitions while the foreign exchange effect was negative for €28,328 thousand (- 5.7%).
| (€ thousands) | First nine months 2023 |
% on Total | First nine months 2022 |
% on Total | Change | Change % | Exchange diff. | Change % in local currency |
|---|---|---|---|---|---|---|---|---|
| EMEA | 1,067,232 | 64.9% | 1,019,254 | 66.2% | 47,978 | 4.7% | (2,003) | 4.9% |
| Americas | 321,984 | 19.6% | 282,043 | 18.3% | 39,941 | 14.2% | (24,002) | 22.7% |
| Asia Pacific | 255,511 | 15.5% | 237,986 | 15.5% | 17,525 | 7.4% | (19,119) | 15.4% |
| Corporate | 338 | 0.0% | 412 | 0.0% | (74) | -18.0% | - | -18.0% |
| Total | 1,645,065 | 100.0% | 1,539,695 | 100.0% | 105,370 | 6.8% | (45,124) | 9.7% |
The breakdown of revenues from sales and services by geographic area is shown below.


| Period (€ thousands) | 2023 | 2022 | Change | Change % |
|---|---|---|---|---|
| I quarter | 359,707 | 340,171 | 19,536 | 5.7% |
| II quarter | 375,775 | 364,478 | 11,297 | 3.1% |
| I Half Year | 735,482 | 704,649 | 30,833 | 4.4% |
| III quarter | 331,750 | 314,605 | 17,145 | 5.4% |
| First nine months | 1,067,232 | 1,019,254 | 47,978 | 4.7% |
Europe, Middle-East and Africa
Consolidated revenues from sales and services amounted to €1,067,232 thousand in the first nine months of 2023, an increase of €47,978 thousand (+4.7%) compared to the same period of the prior year, of which €40,465 thousand (+4.0%) is attributable to organic growth. Acquisitions contributed €9,516 thousand (+0.9%), while the foreign exchange effect was negative for €2,003 thousand (-0.2%).
Even though market demand was weaker than expected and there was one less working day than in the same period of 2022, organic growth still outpaced the reference market, benefitting from increased market share in key countries and the positive impact of price policies.
The contribution of acquisitions refers mainly to the bolt-on acquisitions made in France and Germany in the first nine months of 2023.
In the third quarter alone, consolidated revenues from sales and services amounted to €331,750 thousand, an increase of €17,145thousand (+5.4%) against the comparison period. This increase is attributable to organic growth for €15,690 thousand (+5.0%) and to acquisitions for €2,425 thousand (+0.8%). The foreign exchange effect was slightly negative at €970 thousand (-0.4%).
| Period (€ thousands) | 2023 | 2022 | Change | Change % |
|---|---|---|---|---|
| I quarter | 100,865 | 84,021 | 16,844 | 20.0% |
| II quarter | 111,797 | 96,769 | 15,028 | 15.5% |
| I Half Year | 212,662 | 180,790 | 31,872 | 17.6% |
| III quarter | 109,322 | 101,254 | 8,068 | 8.0% |
| First nine months | 321,984 | 282,043 | 39,941 | 14.2% |
Americas
Consolidated revenues from sales and services amounted to €321,984 thousand in the first nine months of 2023, an increase of €39,941 thousand (+14.2%) compared to the first nine months of 2022. This excellent result is explained for €44,497 thousand (+15.8%) by organic growth fueled primarily by the outstanding performance of Miracle-Ear and Amplifon Hearing Health Care. Acquisitions contributed €19,446 thousand (+6.9%), while the foreign exchange effect was negative for €24,002 thousand (-8.5%).


In addition to the excellent performance reported in the United States, there was also significant growth in Latin America.
In the third quarter alone, consolidated revenues from sales and services amounted to €109,322 thousand, an increase of €8,068 thousand (+8.0%) against the comparison period attributable for €17,539 thousand (+17.3%) to organic growth and for €7,354 thousand (+7.3%) to acquisitions, while the foreign exchange effect was negative for €16,825 thousand (-16.6%).
| Period (€ thousands) | 2023 | 2022 | Change | Change % |
|---|---|---|---|---|
| I quarter | 79,595 | 71,462 | 8,133 | 11.4% |
| II quarter | 85,786 | 80,031 | 5,755 | 7.2% |
| I Half Year | 165,381 | 151,493 | 13,888 | 9.2% |
| III quarter | 90,130 | 86,493 | 3,637 | 4.2% |
| First nine months | 255,511 | 237,986 | 17,525 | 7.4% |
Asia Pacific
Consolidated revenues from sales and services amounted to €255,511 thousand in the first nine months of 2023, an increase of €17,525 thousand (+7.4%) compared to the first nine months of 2022 explained primarily by organic growth, for €32,735 thousand (+13.8%), and acquisitions made in China for €3,909 thousand (+1.6%), while the foreign exchange effect was negative for €19,119 thousand (-8.0%).
In the third quarter alone consolidated revenues from sales and services amounted to €90,130 thousand, an increase of €3,637 thousand (+4.2%), attributable primarily to positive organic growth for €12,028 thousand (+13.9%) and acquisitions made in China for €2,142 thousand (+2.5%) while the foreign exchange effect was negative for €10,533 thousand (-12.2%).
Gross operating profit (EBITDA)
| (€ thousands) | First nine months 2023 | First nine months 2022 | ||||
|---|---|---|---|---|---|---|
| Recurring | Non - recurring |
Total | Recurring | Non - recurring |
Total | |
| Gross operating profit (loss) (EBITDA) | 385,806 | (13,221) | 372,585 | 369,530 | (5,681) | 363,849 |
| (€ thousands) | Third Quarter 2023 | Third Quarter 2022 | ||||
| Recurring | Non - recurring |
Total | Recurring | Non - recurring |
Total | |
| Gross operating profit (loss) (EBITDA) | 109,765 | (1,937) | 107,828 | 109,414 | (652) | 108,762 |
Gross operating profit (EBITDA) amounted to €372,585 thousand in the first nine months of 2023, an increase of €8,736 thousand (+2.4%) with respect to the comparison period. The EBITDA margin came to 22.6%, 1.0 p.p. lower than in the comparison period due to the decreased operating leverage in EMEA explained by the significant investments made to support future growth in a market that was weaker than expected.
The result for the reporting period reflects non-recurring expenses of €13,221 thousand explained:
- for €11,614 thousand, by the notional cost of the free, one-off assignment made by the shareholder Ampliter of 500,000 of its Amplifon shares to the Chief Executive Officer Enrico Vita, recognized in the reporting period in accordance with IFRS 2 "Share Based Payments". For more information refer to section 14 of this report;
- for €1,433 thousand, by the second phase of the GAES integration;
- for €174 thousand, by the Bay Audio integration.
In the first nine months of 2022 non-recurring expenses of €5,681 thousand were also incurred. Net of these items, EBITDA would have been €16,276 thousand (+4.4%) higher than in the first nine months of 2022 with a decrease in the EBITDA margin of -0.5 p.p.
In the third quarter alone, the gross operating profit (EBITDA) amounted to €107,828 thousand, a decrease of €934 thousand (-0.9%) with respect to the comparison period. The EBITDA margin came to 20.3%, 1.3 p.p. lower than in the comparison period.
The result for the quarter reflects non-recurring expenses of €1,937 thousand explained:
- for €1,220 thousand, by the notional cost of the free assignment of shares described above;
- for €543 thousand, by the second phase of the GAES integration.
- for €174 thousand, by the Bay Audio integration.

In the third quarter of 2022 non-recurring expenses of €652 thousand were also incurred. Net of this item, recurring EBITDA would have been €351 thousand (+0.3%) higher than in the third quarter of 2022 with a decrease in the EBITDA margin of -1.1 p.p.
| (€ thousands) | First nine months 2023 |
EBITDA Margin |
First nine months 2022 |
EBITDA Margin |
Change | Change % |
|---|---|---|---|---|---|---|
| EMEA | 298,834 | 28.0% | 289,847 | 28.4% | 8,987 | 3.1% |
| Americas | 83,949 | 26.1% | 73,456 | 26.0% | 10,493 | 14.3% |
| Asia Pacific | 66,292 | 25.9% | 60,016 | 25.2% | 6,276 | 10.5% |
| Corporate (*) | (76,490) | -4.6% | (59,470) | -3.9% | (17,020) | -28.6% |
| Total | 372,585 | 22.6% | 363,849 | 23.6% | 8,736 | 2.4% |
| (€ thousands) | Q3 2023 | EBITDA Margin |
Q3 2022 | EBITDA Margin |
Change | Change % |
| EMEA | 82,345 | 24.8% | 81,676 | 26.0% | 669 | 0.8% |
| Americas | 26,845 | 24.6% | 24,910 | 24.6% | 1,935 | 7.8% |
| Asia Pacific | 23,670 | 26.3% | 22,495 | 26.0% | 1,175 | 5.2% |
| Corporate (*) | (25,032) | -4.7% | (20,319) | -4.0% | (4,713) | -23.2% |
| Total | 107,828 | 20.3% | 108,762 | 21.6% | (934) | -0.9% |
The breakdown of EBITDA by geographic region is shown below.
(*) Centralized costs are shown as a percentage of the Group's total sales
The table below shows the breakdown of the EBITDA by segment with reference to the recurring operations.
| (€ thousands) | First nine months 2023 |
EBITDA Margin |
First nine months 2022 |
EBITDA Margin |
Change | Change % |
|---|---|---|---|---|---|---|
| EMEA | 300,267 | 28.1% | 291,873 | 28.6% | 8,394 | 2.9% |
| Americas | 83,949 | 26.1% | 73,456 | 26.0% | 10,493 | 14.3% |
| Asia Pacific | 66,465 | 26.0% | 62,671 | 26.3% | 3,794 | 6.1% |
| Corporate (*) | (64,875) | -3.9% | (58,470) | -3.8% | (6,405) | -11.0% |
| Total | 385,806 | 23.5% | 369,530 | 24.0% | 16,276 | 4.4% |
| (€ thousands) | Q3 2023 | EBITDA Margin |
Q3 2022 | EBITDA Margin |
Change | Change % |
| EMEA | 82,889 | 25.0% | 82,020 | 26.1% | 869 | 1.1% |
| Americas | 26,845 | 24.6% | 24,910 | 24.6% | 1,935 | 7.8% |
| Asia Pacific | 23,843 | 26.5% | 22,803 | 26.4% | 1,040 | 4.6% |
| Corporate (*) | (23,812) | -4.5% | (20,319) | -4.0% | (3,493) | -17.2% |
| Total | 109,765 | 20.7% | 109,414 | 21.8% | 351 | 0.3% |
(*) Centralized costs are shown as a percentage of the Group's total sales

Europe, Middle-East and Africa
Gross operating profit (EBITDA) amounted to €298,834 thousand in the first nine months of 2023, an increase of €8,987 thousand (+3.1%) with respect to the comparison period. The EBITDA margin came to 28.0%, 0.4 p.p. lower than in the first nine months of 2022 explained
by the significant investments made to support future growth in a market that was weaker than expected.
The result for the reporting period reflects non-recurring expenses of €1,433 thousand attributable to the second phase of the GAES integration.
In the first nine months of 2022 non-recurring expenses of €2,026 thousand were also incurred. Net of this item, EBITDA would have been €8,394 thousand (+2.9%) higher than in the first nine months of 2022 with the EBITDA margin down -0.5 p.p.
In the third quarter alone gross operating profit (EBITDA) amounted to €82,345 thousand, an increase of €669 thousand (+0.8%) with respect to the comparison period. The EBITDA margin was -1.2 p.p. lower than in the comparison period for the same reasons described above.
The result for the reporting period reflects non-recurring expenses of €543 thousand attributable to the second phase of the GAES integration.
In the third quarter of 2022 non-recurring expenses of €344 thousand were also incurred.
Net of this item, recurring EBITDA would have been €869 thousand (+1.1%) higher than in the third quarter of 2022 with the EBITDA margin down -1.1 p.p.
Americas
Gross operating profit (EBITDA) amounted to €83,949 thousand in the first nine months of 2023, an increase of €10,493 thousand (+14.3%) with respect to the comparison period. The EBITDA margin came to 26.1 %, +0.1 p.p. higher than in the first nine months of 2022.
In the third quarter alone, the gross operating profit (EBITDA) amounted to €26,845 thousand, an increase of €1,935 thousand (+7.8%) with respect to the comparison period. The EBITDA margin came to 24.6%, in line with the comparison period.
Asia Pacific
Gross operating profit (EBITDA) amounted to €66,292 thousand in the first nine months of 2023, an increase of €6,276 thousand (+10.5%) with respect to the comparison period. The EBITDA margin came to 25.9 %, +0.7 p.p. higher than in the first nine months of 2022.
Non-recurring expenses, relating to the Bay Audio integration, of €174 thousand were incurred in the reporting period.
In the first nine months of 2022 non-recurring costs amounted to €2,655 thousand.
Net of these items, EBITDA would have been €3,794 thousand higher (+6.1%) with the EBITDA margin down -0.3 p.p.

In the third quarter alone gross operating profit (EBITDA) amounted to €23,670 thousand, an increase of €1,175 thousand (+5.2%) with respect to the comparison period.
The EBITDA margin was +0.3 p.p. higher than in the comparison period, coming in at 26.3%. Non-recurring expenses, relating to the Bay Audio integration, of €174 thousand were incurred in the reporting period.
In the third quarter of 2022 non-recurring expenses amounted to €308 thousand. Net of these items, EBITDA would have been €1,040 thousand (+4,6%) higher with the margin up +0.1 p.p.
Corporate
In the first nine months of 2023 the net cost of centralized corporate functions (corporate bodies, general management, business development, procurement, treasury, legal affairs, human resources, IT systems, global marketing and internal audit) which do not qualify as operating segments under IFRS 8 amounted to €76,490 thousand, €17,020 thousand higher (- 28.6%) with respect to the same period of the prior year. The EBITDA margin came to -4.6% (0.7 p.p. higher than in the first nine months of 2022).
The result for the reporting period reflects the non-recurring expenses of €11,614 thousand stemming from the portion of the notional cost of the free, one-off assignment made by the shareholder Ampliter of 500,000 of its Amplifon shares to the Chief Executive Officer Enrico Vita recognized in the reporting period. For more information refer to Note 14 of this report.
In the first nine months of 2022 non-recurring expenses of €1,000 thousand were also recognized.
Net of these items, costs would have been €6,405 thousand (11.0%) higher than in the first nine months of 2022, with the margin lower by 0.1 p.p.
In the third quarter the corporate costs amounted to €25,032 thousand (-4.7% of the revenues generated by the Group's sales and services), €4,713 thousand (+23.2%) higher than in the third quarter of 2022.
The result for the third quarter reflects the non-recurring expenses of €1,220 thousand stemming from the notional cost of the assignment of shares described above.
Net of these items, costs would have been €3,493 thousand (+17.2%) higher than in the third quarter of 2022 with the margin up 0.5 p.p.
Operating profit (loss) (EBIT)
| (€ thousands) | First nine months 2023 | First nine months 2022 | ||||
|---|---|---|---|---|---|---|
| Recurring | Non - recurring |
Total | Recurring | Non - recurring |
Total | |
| Operating profit (loss) (EBIT) | 192,890 | (13,221) | 179,669 | 191,252 | (5,681) | 185,571 |
| (€ thousands) | Third quarter 2023 | Third quarter 2022 | ||||
| Recurring | Non - recurring |
Total | Recurring | Non - recurring |
Total | |
| Operating profit (loss) (EBIT) | 45,390 | (1,937) | 43,453 | 49,056 | (652) | 48,404 |
Operating profit (EBIT) amounted to €179,669 thousand in the first nine months of 2023, a decrease of €5,902 thousand (-3.2%) with respect to the comparison period.
The EBIT margin came to 10.9%, a decrease of 1.2 p.p. against the comparison period.
With respect to the gross operating profit (EBITDA), EBIT was also impacted by an increase in depreciation and amortization of €14,638 thousand as a result of investments in IT systems, the opening of new stores, as well as higher amortization for right-of-use assets.
The reporting period was impacted for €13,221 thousand by the same non-recurring expenses described in the section on EBITDA. In the first nine months of 2022 non-recurring expenses amounted to €5,681 thousand. Net of these items, EBIT would have been €1,638 thousand higher (+0.9%) than in the first nine months of 2022, with the EBIT margin down -0.7 p.p.
In the third quarter alone operating profit (EBIT) amounted to €43,453 thousand, a decrease of €4,951 thousand (-10.2%) against the comparison period. The EBIT margin was 1.4 p.p. lower than in the third quarter of 2022, coming in at 8.2%.
With respect to the gross operating profit (EBITDA), EBIT was also impacted by an increase in amortization and depreciation of €4,017 thousand.
The third quarter was impacted for €1,938 thousand by the same non-recurring expenses described in the section on EBITDA. In the third quarter of 2022 non-recurring expenses, described in the section on EBITDA, amounted to €652 thousand. Net of these items, recurring EBIT would have been €3,666 thousand (-7.5%) lower than in the third quarter of 2022 with the margin down -1.3 p.p.

| (€ thousands) | First nine months 2023 |
EBIT Margin |
First nine months 2022 |
EBIT Margin |
Change | Change % |
|---|---|---|---|---|---|---|
| EMEA | 185,290 | 17.4% | 180,357 | 17.7% | 4,933 | 2.7% |
| Americas | 63,220 | 19.6% | 56,626 | 20.1% | 6,594 | 11.6% |
| Asia Pacific | 27,734 | 10.9% | 23,813 | 10.0% | 3,921 | 16.5% |
| Corporate (*) | (96,575) | -5.9% | (75,225) | -4.9% | (21,350) | -28.4% |
| Total | 179,669 | 10.9% | 185,571 | 12.1% | (5,902) | -3.2% |
| (€ thousands) | Q3 2023 | EBIT Margin |
Q3 2022 | EBIT Margin |
Change | Change % |
| EMEA | 44,073 | 13.3% | 45,067 | 14.3% | (994) | -2.2% |
| Americas | 19,828 | 18.1% | 18,884 | 18.7% | 944 | 5.0% |
| Asia Pacific | 11,687 | 13.0% | 10,252 | 11.9% | 1,435 | 14.0% |
| Corporate (*) | (32,135) | -6.0% | (25,799) | -5.1% | (6,336) | -24.6% |
The breakdown of EBIT by segment is shown below.
(*) Centralized costs are shown as a percentage of the Group's total sales.
The table below shows the breakdown of the EBIT by segment with reference to the recurring operations.
| (€ thousands) | First nine months 2023 |
EBIT Margin |
First nine months 2022 |
EBIT Margin |
Change | Change % |
|---|---|---|---|---|---|---|
| EMEA | 186,723 | 17.5% | 182,383 | 17.9% | 4,340 | 2.4% |
| Americas | 63,220 | 19.6% | 56,626 | 20.1% | 6,594 | 11.6% |
| Asia Pacific | 27,907 | 10.9% | 26,468 | 11.1% | 1,439 | 5.4% |
| Corporate (*) | (84,960) | -5.2% | (74,225) | -4.8% | (10,735) | -14.5% |
| Total | 192,890 | 11.7% | 191,252 | 12.4% | 1,638 | 0.9% |
| (€ thousands) | Q3 2023 | EBIT Margin |
Q3 2022 | EBIT Margin |
Change | Change % |
| EMEA | 44,617 | 13.4% | 45,411 | 14.4% | (794) | -1.7% |
| Americas | 19,828 | 18.1% | 18,884 | 18.7% | 944 | 5.0% |
| Asia Pacific | 11,860 | 13.2% | 10,560 | 12.2% | 1,300 | 12.3% |
| Corporate (*) | (30,915) | -5.8% | (25,799) | -5.1% | (5,116) | -19.8% |
| Total | 45,390 | 8.5% | 49,056 | 9.8% | (3,666) | -7.5% |
(*) Centralized costs are shown as a percentage of the Group's total sales.

Europe, Middle-East and Africa
Operating profit (EBIT) amounted to €185,290 thousand in the first nine months of 2023, an increase of €4,933 thousand (+2.7%) with respect to the comparison period. The EBIT margin came to 17.4%, 0.3 p.p. lower than in the comparison period.
The result was impacted for €1,433 thousand by the same non-recurring expenses described in the section on EBITDA. In the first nine months of 2022 non-recurring expenses amounted to €2,026 thousand.
Net of these items, EBIT would have been €4,340 thousand higher (+2.4%) than in the first nine months of 2022, with the EBIT margin down -0.4 p.p.
In the third quarter alone operating profit (EBIT) amounted to €44,073 thousand, a decrease of €994 thousand (-2.2%) against the comparison period with the EBIT margin 1.0 p.p. lower than in the comparison period at 13.3%.
The result for the quarter was impacted for €544 thousand by the same non-recurring expenses described in the section on EBITDA. In the third quarter of 2022 non-recurring expenses amounted to €344 thousand. Net of these items, recurring EBIT would have been €794 thousand lower (-1.7%) than in the third quarter of 2022, with a 1.0 p.p. decrease in the EBIT margin.
Americas
Operating profit (EBIT) amounted to €63,220 thousand in the first nine months of 2023, an increase of €6,594 thousand (+11.6%) with respect to the comparison period. The EBIT margin came to 19.6%, 0.5 p.p. lower than in the first nine months of 2022.
In the second quarter alone operating profit (EBIT) amounted to €19,828 thousand, an increase of €944 thousand (+5.0%) with respect to the comparison period. The EBIT margin was 0.6 p.p. lower, coming in at 18.1%.
Asia Pacific
Operating profit (EBIT) amounted to €27,734 thousand in the first nine months of 2023, an increase of €3,921 thousand (+16.5%) with respect to the comparison period. The EBIT margin came to 10.9%, 0.9 p.p. higher than in the first nine months of 2022.
The result of the period reflects non-recurring expenses of €174 thousand, relating to the second phase of the Bay Audio integration.
In the first nine months of 2022 non-recurring expenses amounted to €2,655 thousand. Net of these items EBIT would have been €1,439 thousand (+5,4%) higher and the margin would have been -0.2 p.p. lower.


In the third quarter alone operating profit (EBIT) amounted to €11,687 thousand, an increase of €1,435 thousand (+14.0%) with respect to the comparison period. The EBIT margin came to 13.0%, 1.1 p.p. higher than in the third quarter of 2022.
The result for the quarter was impacted for €174 thousand by the same non-recurring expenses described in the section on EBITDA. In the third quarter of 2022 non-recurring expenses amounted to €308 thousand. Net of these items, recurring EBIT would have been €1,300 thousand higher (+12.3%), with the EBIT margin up 1.0 p.p.
Corporate
The net Corporate costs at the EBIT level amounted to €96,575 thousand in the first nine months of 2023 (-5.9% of the revenues generated by the Group's sales and services), an increase of €21,350 thousand compared to the first nine months of 2022.
The result was impacted for €11,614 thousand by the non-recurring expenses described in the section on EBITDA. In the first nine months of 2022 non-recurring expenses amounted to €1,000 thousand.
Net of these items, the costs would have been €10,735 thousand (+14.5%) higher with the margin up 0.4 p.p.
In the third quarter alone the net Corporate costs at the EBIT level amounted to €32,135 thousand (-6.0% of the revenues generated by the Group's sales and services), an increase of €6,336 thousand (+24.6%) compared to the third quarter of 2022.
The quarter was impacted for €1,220 thousand by the same non-recurring expenses described in the section on EBITDA.
Net of this item, the costs would have been €5,116 thousand (+19.8%) higher than in the third quarter of 2022 with the margin up +0.7 p.p.
Profit before taxes
| (€ thousands) | First nine months 2023 | First nine months 2022 | ||||
|---|---|---|---|---|---|---|
| Recurring | Non - recurring |
Total | Recurring | Non - recurring |
Total | |
| Profit before taxes | 155,997 | (13,221) | 142,776 | 165,680 | (5,681) | 159,999 |
| (€ thousands) | Third quarter 2023 | Third quarter 2022 | ||||
| Recurring | Non - recurring |
Total | Recurring | Non - recurring |
Total | |
| Profit before taxes | 32,214 | (1,937) | 30,277 | 40,784 | (652) | 40,132 |
Profit before tax amounted to €142,776 thousand in the first nine months of 2023, a decrease of €17,223 thousand (-10.8%) against the comparison period, with a gross profit margin of 8.7% (-1.7 p.p. with respect to the comparison period).
The result for the first nine months of 2023 was impacted for €13,221 thousand by the same non-recurring expenses described in the section on EBITDA. In the first nine months of 2022 nonrecurring expenses of €5,681 thousand were incurred. Net of this item and, therefore, on a recurring basis, there would have been a decrease of €9,683 thousand (-5.8%) against the first nine months of 2022, with the profit margin down 1.3 p.p.
In addition to the change in EBIT described above, this result reflects an increase in net financial expenses of €11,321 thousand due mainly to: (i) the impact of higher interest rates on the utilization of short-term credit lines, on the floating rates applied to medium/long-term credit lines, on factoring and lease accounting; (ii) the exchange differences tied to currency volatility mainly in countries in North and South America; (iii) the more adverse impact of inflation accounting on the Argentinian subsidiary.
In the third quarter alone profit before tax amounted to €30,277 thousand, a decrease of €9,855 thousand (-24.6%) with respect to the comparison period, with a gross profit margin of 5.7% (- 2.3 p.p. against the comparison period).
The result recorded in the third quarter of 2023 was impacted for €1,937 thousand by the same non-recurring expenses described in the section on EBITDA. In the third quarter of 2022 nonrecurring expenses amounted to €652 thousand. Net of these items, profit before tax would have been €8,570 thousand (-21.0%) lower than in the third quarter of 2022. The gross profit margin would have been 2.0 p.p. lower, coming in at 6.1%.

Group net profit
| (€ thousands) | First nine months 2023 | First nine months 2022 | |||||
|---|---|---|---|---|---|---|---|
| Recurring | Non - recurring |
Total | Recurring | Non - recurring |
Total | ||
| Group net profit | 112,815 | (9,377) | 103,438 | 119,577 | (4,093) | 115,484 | |
| (€ thousands) | Third quarter 2023 | Third quarter 2022 | |||||
| Recurring | Non - recurring |
Total | Recurring | Non - recurring |
Total | ||
| Group net profit | 23,471 | (1,389) | 22,082 | 29,679 | (475) | 29,204 |
The Group's net profit came to €103,438 thousand in the first nine months of 2023, a decrease of €12,046 thousand (-10.4%) against the comparison period, with a profit margin of 6.3% (-1.2 p.p. against the comparison period).
The result for the reporting period was impacted for €9,337 thousand by the same non-recurring expenses described above, net of the tax effect. In the first nine months of 2022 non-recurring expenses amounted to €4,093 thousand. On a recurring basis, the decrease would have amounted to €6,762 thousand (-5.7%) with respect to the first nine months of 2022, with the profit margin down 0.9 p.p.
The tax rate was 27.6% in the reporting period compared to 27.7% in the first nine months of 2022.
In the third quarter alone the Group's net profit came to €22,082 thousand (4.2% of revenues from sales and services), a decrease of €7,122 thousand (-24.4%) against the comparison period with the profit margin down -1.6 p.p. Net of the non-recurring expenses, the Group's net profit would have been €6,208 thousand (-20.9%) lower, with the profit margin down -1.5 p.p.
BALANCE SHEET REVIEW
Consolidated balance sheet by geographical area (*)
| (€ thousands) | 09/30/2023 | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Eliminations | Total | |
| Goodwill | 945,325 | 247,211 | 601,787 | - | 1,794,323 |
| Non-competition agreements, trademarks, customer lists and lease rights |
182,946 | 22,564 | 54,882 | - | 260,392 |
| Software, licenses, other intangible fixed assets with finite useful life, fixed assets in progress and advances |
122,329 | 33,890 | 8,553 | - | 164,772 |
| Property, plant, and equipment | 144,014 | 26,588 | 37,095 | - | 207,697 |
| Right-of-use assets | 367,257 | 45,463 | 55,506 | - | 468,226 |
| Financial fixed assets | 3,938 | 11,972 | 198 | - | 16,108 |
| Other non-current financial assets | 41,173 | 2,505 | 1,667 | - | 45,345 |
| Non-current assets | 1,806,982 | 390,193 | 759,688 | - | 2,956,863 |
| Inventories | 68,809 | 6,384 | 9,519 | - | 84,712 |
| Trade receivables | 206,424 | 36,781 | 20,602 | (60,918) | 202,889 |
| Other receivables | 87,823 | 11,348 | 9,243 | (195) | 108,219 |
| Current assets (A) | 363,056 | 54,513 | 39,364 | (61,113) | 395,820 |
| Operating assets | 2,170,038 | 444,706 | 799,052 | (61,113) | 3,352,683 |
| Trade payables | (269,587) | (68,429) | (47,356) | 60,918 | (324,454) |
| Other payables | (273,627) | (39,121) | (33,466) | 195 | (346,019) |
| Provisions for risks and charges (current portion) |
(265) | (710) | - | - | (975) |
| Current liabilities (B) | (543,479) | (108,260) | (80,822) | 61,113 | (671,448) |
| Net working capital (A) - (B) | (180,423) | (53,747) | (41,458) | - | (275,628) |
| Derivative instruments | 19,429 | - | - | - | 19,429 |
| Deferred tax assets | 65,713 | 11,527 | 10,953 | - | 88,193 |
| Deferred tax liabilities | (62,396) | (26,176) | (17,325) | - | (105,897) |
| Provisions for risks and charges (non current portion) |
(17,298) | (841) | (1,372) | - | (19,511) |
| Liabilities for employees' benefits (non current portion) |
(9,141) | (200) | (758) | - | (10,099) |
| Loan fees | 3,448 | - | - | - | 3,448 |
| Other non-current liabilities | (163,937) | (14,477) | (2,401) | - | (180,815) |
| NET INVESTED CAPITAL | 1,462,377 | 306,279 | 707,327 | - | 2,475,983 |
| Group net equity | 1,069,770 | ||||
| Minority interests | 945 | ||||
| Total net equity | 1,070,715 | ||||
| Net medium and long-term financial indebtedness |
665,982 | ||||
| Net short-term financial indebtedness | 251,651 | ||||
| Total net financial indebtedness | 917,633 | ||||
| Lease liabilities | 380,192 | 48,826 | 58,617 | 487,635 | |
| Total lease liabilities & net financial indebtedness |
1,405,268 | ||||
| NET EQUITY, LEASE LIABILITIES AND NET FINANCIAL INDEBTEDNESS |
2,475,983 |
(*) The balance sheet items are analyzed by the Chief Executive Officer and the Top Management by geographical area without separation of the Corporate structures that are natively included in EMEA.
| (€ thousands) | 12/31/2022 | ||||
|---|---|---|---|---|---|
| EMEA | Americas | Asia Pacific | Eliminations | Total | |
| Goodwill | 921,163 | 213,816 | 619,049 | - | 1,754,028 |
| Non-competition agreements, trademarks, customer lists and lease rights |
185,759 | 22,022 | 58,344 | - | 266,125 |
| Software, licenses, other intangible fixed assets with finite useful life, fixed assets in progress and advances |
112,883 | 31,881 | 9,209 | - | 153,973 |
| Property, plant, and equipment | 136,721 | 21,006 | 35,688 | - | 193,415 |
| Right-of-use assets | 366,243 | 34,242 | 51,262 | - | 451,747 |
| Financial fixed assets | 3,706 | 9,378 | 208 | - | 13,292 |
| Other non-current financial assets | 38,589 | 2,322 | 1,491 | - | 42,402 |
| Non-current assets | 1,765,064 | 334,667 | 775,251 | - | 2,874,982 |
| Inventories | 60,417 | 5,781 | 10,060 | - | 76,258 |
| Trade receivables | 211,132 | 46,331 | 28,617 | (94,014) | 192,066 |
| Other receivables | 64,120 | 8,520 | 5,450 | (199) | 77,891 |
| Current assets (A) | 335,669 | 60,632 | 44,127 | (94,213) | 346,215 |
| Operating assets | 2,100,733 | 395,299 | 819,378 | (94,213) | 3,221,197 |
| Trade payables | (310,412) | (68,611) | (40,574) | 94,014 | (325,583) |
| Other payables | (284,580) | (35,345) | (40,735) | 199 | (360,461) |
| Provisions for risks and charges (current portion) |
(975) | (688) | - | - | (1,663) |
| Current liabilities (B) | (595,967) | (104,644) | (81,309) | 94,213 | (687,707) |
| Net working capital (A) - (B) | (260,298) | (44,012) | (37,182) | - | (341,492) |
| Derivative instruments | 24,474 | - | - | - | 24,474 |
| Deferred tax assets | 60,867 | 10,206 | 10,707 | - | 81,780 |
| Deferred tax liabilities | (61,419) | (26,053) | (19,211) | - | (106,683) |
| Provisions for risks and charges (non current portion) |
(17,712) | (787) | (1,445) | - | (19,944) |
| Liabilities for employees' benefits (non current portion) |
(8,024) | (202) | (714) | - | (8,940) |
| Loan fees | 4,508 | - | - | - | 4,508 |
| Other non-current liabilities | (151,723) | (15,718) | (2,295) | - | (169,736) |
| NET INVESTED CAPITAL | 1,355,737 | 258,101 | 725,111 | - | 2,338,949 |
| Group net equity | 1,038,509 | ||||
| Minority interests | 1,841 | ||||
| Total net equity | 1,040,350 | ||||
| Net medium and long-term financial indebtedness |
807,907 | ||||
| Net short-term financial indebtedness | 22,086 | ||||
| Total net financial indebtedness | 829,993 | ||||
| Lease liabilities | 377,981 | 36,822 | 53,803 | - | 468,606 |
| Total lease liabilities & net financial indebtedness |
1,298,599 | ||||
| NET EQUITY, LEASE LIABILITIES AND NET FINANCIAL INDEBTEDNESS |
2,338,949 |

Non-current assets
Non-current assets amounted to €2,956,863 thousand at 30 September 2023, an increase of €81,881 thousand respect to the €2,874,982 thousand recorded at 31 December 2022.
The changes in the period are explained (i) for €101,660 thousand by capital expenditure; (ii) for €104,991 thousand by the recognition of right-of-use assets acquired in the period; (iii) for €92,226 thousand by acquisitions made in the reporting period; (iv) for €193,413 thousand by depreciation, amortization and impairment which includes the amortization of the above rightof-use assets; (v) for €23,583 thousand by other net decreases relating primarily to negative foreign exchange differences.
The following table shows the breakdown of non-current assets by geographical segment.
| (€ thousands) | 09/30/2023 | 12/31/2022 | Change | |
|---|---|---|---|---|
| Goodwill | 945,325 | 921,163 | 24,162 | |
| Non-competition agreements, trademarks, customer lists and lease rights |
182,946 | 185,759 | (2,813) | |
| Software, licenses, other intangible fixed assets with finite useful life, fixed assets in progress and advances |
112,883 | 9,446 | ||
| EMEA | Property, plant, and equipment | 136,721 | 7,293 | |
| Right-of-use assets | 366,243 | 1,014 | ||
| Financial fixed assets | 3,706 | 232 | ||
| Other non-current financial assets | 38,589 | 2,584 | ||
| Non-current assets | 1,806,982 | 1,765,064 | 41,918 | |
| Goodwill | 247,211 | 213,816 | 33,395 | |
| Non-competition agreements, trademarks, customer lists and lease rights |
22,564 | 22,022 | 542 | |
| Software, licenses, other intangible fixed assets with finite useful life, fixed assets in progress and advances |
33,890 | 31,881 | 2,009 | |
| Americas | Property, plant, and equipment | 26,588 | 21,006 | 5,582 |
| Right-of-use assets | 45,463 | 34,242 | 11,221 | |
| Financial fixed assets | 11,972 | 9,378 | 2,594 | |
| Other non-current financial assets | 2,505 | 2,322 | 183 | |
| Non-current assets | 390,193 | 334,667 | 55,526 | |
| Goodwill | 601,787 | 619,049 | (17,262) | |
| Non-competition agreements, trademarks, customer lists and lease rights |
54,882 | 58,344 | (3,462) | |
| Software, licenses, other intangible fixed assets with finite useful life, fixed assets in progress and advances |
8,553 | 9,209 | (656) | |
| Asia Pacific | Property, plant, and equipment | 37,095 | 35,688 | 1,407 |
| Right-of-use assets | 55,506 | 51,262 | 4,244 | |
| Financial fixed assets | 198 | 208 | (10) | |
| Other non-current financial assets | 1,667 | 1,491 | 176 | |
| Non-current assets | 759,688 | 775,251 | (15,563) | |
| Total | 2,956,863 | 2,874,982 | 81,881 |

Europe, Middle-East and Africa
Non-current assets amounted to €1,806,982 thousand at 30 September 2023, an increase of €41,918 thousand with respect to the €1,765,064 thousand recorded at 31 December 2022. This increase is explained:
- for €59,788 thousand, by right-of-use assets acquired in the year as a result of the renewal of existing leases and network expansion.
- for €38,631 thousand, by acquisitions made in the reporting period;
- for €33,040 thousand, by investments in plant, property and equipment, relating primarily to the opening of new stores and the renewal of existing ones, as well as the purchase of hardware needed to implement Group IT projects detailed below;
- for €42,437 thousand, by investments in intangible assets, relating to new front office solutions for the hyper-personalization of customer experiences and continuous implementation and standardization of the Group ERP cloud system for back-office functions (Human Resources, Procurement, Administration and Finance);
- for €134,126 thousand, by amortization, depreciation and impairment, including amortization of the right-of-use assets referred to above;
- for €2,148 thousand, by other increases.
Americas
Non-current assets amounted to €390,193 thousand at 30 September 2023, an increase of €55,526 thousand against the €334,667 thousand recorded at 31 December 2022. This increase is explained:
- for €35,368 thousand, by acquisitions made in the reporting period;
- for €19,411 thousand, by right-of-use assets acquired during the year as a result of the renewal of existing leases and network expansion;
- for €8,427 thousand, by investments in property, plant and equipment, relating to the opening of new stores, and the renewal of existing ones;
- for €7,193 thousand, by investments in intangible assets relating mainly to the development of IT systems, primarily at US subsidiaries;
- for €20,729 thousand, by amortization and depreciation, including the amortization of the right-of-use assets referred to above;
- for €8,292 thousand, by foreign exchange losses;
- for €14,148 thousand by other increases, explained primarily by revaluations tied to inflation accounting at the Argentinian subsidiary.
Asia Pacific
Non-current assets amounted to €759,688 thousand at 30 September 2023, a decrease of €15,563 thousand against the €775,251 thousand recorded at 31 December 2022.
The change is explained:
- for €25,792 thousand, by an increase in right-of-use assets acquired during the year as a result of the renewal of existing leases and network expansion;


- for €18,227 thousand, by acquisitions made in the reporting period;
- for €8,880 thousand, by investments in property, plant and equipment, relating mainly to the opening of stores and the renewal of existing ones, as well as the purchase of the hardware needed to implement IT projects;
- for €1,683 thousand, by investments in intangible assets relating primarily to the development of IT systems;
- for €38,558 thousand, by amortization and depreciation, including the amortization of the right-of-use assets referred to above;
- for €31,587 thousand, by other decreases relating to foreign exchange differences which mainly affected goodwill.
Net invested capital
Net invested capital amounted to €2,475,983 thousand at 30 September 2023, an increase of €137,034 thousand against the €2,338,949 thousand recorded at 31 December 2022.
This increase is attributable mainly to the change in non-current assets described above, as well as an increase in working capital.
The breakdown of net invested capital by geographical region is shown below.
| (€ thousands) | 09/30/2023 | 12/31/2022 | Change |
|---|---|---|---|
| EMEA | 1,462,377 | 1,355,737 | 106,640 |
| Americas | 306,279 | 258,101 | 48,178 |
| Asia Pacific | 707,327 | 725,111 | (17,784) |
| Total | 2,475,983 | 2,338,949 | 137,034 |

Europe, Middle-East and Africa
Net invested capital came to €1,462,377 thousand at 30 September 2023, an increase of €106,640 thousand against the €1,355,737 thousand recorded at 31 December 2022.
This increase is attributable mainly to the change in non-current assets described above, as well as an increase in working capital less the increase of other medium/long-term payables. Factoring without recourse in the period involved trade receivables with a face value of €89,446 thousand (€55,298 thousand in the same period of the prior year) and VAT credits with a face value of €19,055 thousand (€5,394 thousand in the same period of the prior year).
Americas
Net invested capital came to €306,279 thousand at 30 September 2023, an increase of €48,178 thousand against the €258,101 thousand recorded at 31 December 2022.
This increase is attributable mainly to the change in non-current assets less a decrease in working capital. Factoring without recourse in the reporting period involved trade receivables with a face value of €1,126 thousand (€1,235 thousand in the same period of the prior year).
Asia Pacific
Net invested capital came to €707,327 thousand at 30 September 2023, a decrease of €17,784 thousand against the €725,111 thousand recorded at 31 December 2022. This decrease is attributable mainly to the decrease in non-current assets, along with the drop in working capital. Factoring without recourse in the period involved trade receivables with a face value of €5,652 thousand.

Net financial indebtness
(*) Net financial indebtedness/EBITDA is the ratio of net financial indebtedness, excluding lease liabilities and short-term investments not cash equivalents, to EBITDA for the last four quarters (determined with reference to recurring operations only, based on pro forma figures in case of significant changes to the structure of the Group).
Excluding lease liabilities, net financial debt amounted to €917,633 thousand at 30 September 2023, an increase of €87,640 thousand compared to 31 December 2022.
In the first nine months of 2023 free cash flow was positive for €68,772 thousand (compared to €142,968 thousand in the first nine months of the prior year) due to higher capital expenditure which totaled €99,833 thousand (vs. €75,363 thousand in the comparison period).
Net cash-outs for acquisitions, which amounted to €83,243 thousand (€52,243 thousand in the first nine months of 2022), along with the payment of €65,361 thousand in dividends (€58,237 thousand in the comparison period) and costs related to other financial assets of €3,878 thousand, bring cash flow for the reporting period to a negative €83,847 thousand versus a negative €10,088 thousand in the first nine months of 2022.
At the end of January 2023, the entire Private Placement 2013-2025 was repaid in advance (€85,371 thousand at the hedging rate). This was the company's most expensive source of financing. The subsequent elimination of the relative financial covenants allowed the Group to further increase its financial flexibility, as well as reduce the total cost of funding.
At the end of May 2023, a new €300 million sustainability-linked revolving line of credit was obtained from a pool of banks. This new facility, with a 3-year term and an extension option for 2 additional years at the Company's discretion, provides Amplifon with greater financial flexibility, further strengthening its solid liquidity position, diversifying the sources of funding and extending the average debt maturity. In July 2023 Amplifon signed a €300 million loan agreement with the European Investment Bank (EIB) to finance its innovation and digitalization


process (out of a total of €350 million in financing approved by the EIB). The loan, unutilized at the end of September 2023, will contribute to the further innovation of Amplifon's products and services, providing an excellent and highly personalized hearing care experience thanks to the use of a full ecosystem built around the customer, in which the quantity and quality of the Company's services, as well as digital technologies, play a key role.
At 30 September 2023, the Group had cash and cash equivalents, as well as other liquid investments, of €197,770 thousand compared to total net financial indebtedness of €1,115 million, net of lease liabilities.
Long-term debt amounts to €665,982 thousand, €6,817 thousand of which refers to the longterm portion of deferred payments for acquisitions. The decrease in the period of €141,925 thousand is attributable mainly to the reclassification of portions of long-term bank debt, expiring in the next 12 months, from long-to short-term.
Short-term debt amounts to €449,421 thousand, an increase of €197,713 thousand compared to 31 December 2022. The short-term portion refers primarily to the short-term portion of longterm bank debt (€197,487 thousand), the hot money accounts used to support treasury activities and other short-term credit lines (€235,281 thousand), the interest payable on the Eurobond (€2,470 thousand) and on other bank loans (€3,944 thousand) and, lastly, the best estimate of the deferred payments for acquisitions (€9,357 thousand).
The chart below shows the debt maturities compared to:
- the €198 million in cash and cash equivalents which includes quotas in low-risk money market funds managed by top-tier financial institutions for €50 million;
- the unutilized portions of irrevocable credit lines which amount to €555 million;
- the unutilized €300 million EIB loan.

The other uncommitted credit lines amount to €42 million.


Interest payable on financial indebtedness amounted to €20,579 thousand at 30 September 2023, €14,101 thousand at 30 September 2022.
Interest payable on leases recognized in accordance with IFRS 16 amounted to €10,846 thousand versus €8,332 thousand at 30 September 2022.
Interest receivable on bank deposits are €1,543 thousand at 30 September 2023 versus €179 thousand at 30 September 2022.
The reasons for the changes in net indebtedness are described in the next section on the statement of cash flows.

CASH FLOW STATEMENT
The reclassified statement of cash flows shows the change in net financial indebtedness from the beginning to the end of the period. Pursuant to IAS 7, the consolidated financial statements include a statement of cash flows that shows the change in cash and cash equivalents from the beginning to the end of the period.
| First nine months | First nine months | |
|---|---|---|
| (€ thousands) OPERATING ACTIVITIES |
2023 | 2022 |
| Net profit (loss) attributable to the Group | 103,438 | 115,484 |
| Minority interests | 3 | 226 |
| Amortization, depreciation and impairment: | ||
| - Intangible fixed assets | 65,345 | 59,096 |
| - Tangible fixed assets | 39,663 | 38,124 |
| - Right-of-use assets | 87,908 | 81,057 |
| Total amortization, depreciation and impairment | 192,916 | 178,277 |
| Provisions, other non-monetary items and gain/losses from disposals | 28,735 | 15,826 |
| Group's share of the result of associated companies | (207) | (322) |
| Financial income and charges | 37,102 | 25,894 |
| Current and deferred income taxes | 39,333 | 44,289 |
| Change in assets and liabilities: | ||
| - Utilization of provisions | (7,356) | (7,726) |
| - (Increase) decrease in inventories | (8,505) | (8,900) |
| - Decrease (increase) in trade receivables | (14,469) | (3,949) |
| - Increase (decrease) in trade payables | 3,011 | 36,111 |
| - Changes in other receivables and other payables | (25,651) | (40,865) |
| Total change in assets and liabilities | (52,970) | (25,329) |
| Dividends received | 3 | 342 |
| Net interest charges | (33,974) | (23,184) |
| Taxes paid | (60,679) | (33,047) |
| Cash flow provided by (used in) operating activities before repayment of lease liabilities | 253,700 | 298,456 |
| Repayment of lease liabilities | (85,095) | (80,125) |
| Cash flow generated from (absorbed) by operating activities | 168,605 | 218,331 |
| INVESTING ACTIVITIES: | ||
| Purchase of intangible fixed assets | (51,313) | (37,172) |
| Purchase of tangible fixed assets | (50,347) | (43,093) |
| Consideration from sale of tangible fixed assets and businesses | 1,827 | 4,902 |
| Cash flow generated from (absorbed) by investing activities | (99,833) | (75,363) |
| Cash flow generated from operating and investing activities (Free cash flow) | 68,772 | 142,968 |
| Business combinations (*) | (83,243) | (52,243) |
| Net cash flow generated from acquisitions | (83,243) | (52,243) |
| Cash flow generated from (absorbed) by investing activities | (183,076) | (127,606) |

Interim Financial Report as at 30 September 2023 > Interim Management Report
| (€ thousands) | First nine months 2023 |
First nine months 2022 |
|---|---|---|
| FINANCING ACTIVITIES | ||
| Hedging instruments | (1,483) | - |
| Other non-current assets | (982) | 904 |
| Treasury Shares | - | (42,872) |
| Commissions on medium/long terms financing | (1,413) | - |
| Dividends | (65,361) | (58,237) |
| Capital increases, third parties' contributions and dividends paid by subsidiaries to third parties |
(137) | (608) |
| Cash flow generated from (absorbed) by financing activities | (69,376) | (100,813) |
| Changes in net financial indebtedness | (83,847) | (10,088) |
| Net financial indebtedness at the beginning of the period | (829,993) | (871,186) |
| Effect of exchange rate fluctuations on net financial indebtedness | (3,793) | (791) |
| Changes in net indebtedness | (83,847) | (10,088) |
| Net financial indebtedness at the end of the period | (917,633) | (882,065) |
(*) The item refers to the net cash flows used in the acquisition of businesses and equity investments.
The change in net financial indebtedness of €83,847 thousand is attributable to:
- (i) Investing activities:
- capital expenditure on property, plant and equipment and intangible assets of €101,660 thousand relating primarily to new front-office solutions, ongoing implementation and standardization of the Group cloud-based ERP system, and network expansion.
- acquisitions amounting to €83,243 thousand, including the impact of the acquired companies' debt and the best estimate of the earn-out linked to sales and profitability targets payable over the next few years;
- net proceeds from the disposal of assets of €1,827 thousand.
- (ii) Operating activities:
- interest payable on financial indebtedness, interest on leases in accordance to IFRS16 application, and other net financial expenses of €33,974 thousand;
- payment of taxes amounting to €60,679 thousand;
- payment of principle on lease obligations of €85,095 thousand;
- cash flow generated by operations of €348,353 thousand.
- (iii) financing activities
- dividends distribution of €65,361 thousand;
- payment of hedging instruments for €1,483 thousand;
- payment of commissions on medium/long term financing of €1,413 thousand;
- change of other non current-assets for €982 thousand.
- (iv) Net debt was also impacted by exchange losses of €3,793 thousand.


Non-recurring transactions had a negative impact on cash flow of €2,740 thousand in the first nine months of 2023 attributable for €1,800 thousand to the costs incurred for GAES Integration, and €940 thousand to the acquisition related cost for Bay Audio acquisition and integration.


ACQUISITION OF COMPANIES AND BUSINESSES
During the first nine months of 2023, the Group continued with external growth operations and acquired 219 points of sale for a total investment of €83,243 thousand, including the debt consolidated and the best estimate of the earn-out linked to sales and profitability targets payable over the next few years.
More in detail, in the first nine months of 2023:
- 93 points of sale were acquired in China;
- 47 points of sale were acquired in Canada;
- 29 points of sale were acquired in Germany;
- 22 points of sale were acquired in France;
- 16 points of sale were acquired in the United States;
- 6 points of sale were acquired in Poland;
- 3 points of sale were acquired in Spain;
- 2 points of sale were acquired in Mexico;
- 1 point of sale was acquired in Italy.

OUTLOOK
In the first nine months of 2023, the Group continued its strong growth path despite a softerthan-expected demand in the European market and a global macroeconomic and geopolitical environment characterized by increasing uncertainty and volatility.
Looking into the fourth quarter of 2023, Amplifon expects:
- the US market to continue to grow healthily, while the European market to remain subdued and below initial expectations;
- to continue to grow organically significantly faster than the market;
- bolt-on acquisitions to contribute at least 2% to the Group's consolidated revenue growth;
- a strong start to the fourth quarter with double-digit revenue growth at constant exchange rates in October.
In light of the above, and with an estimation of exchange rate for 2023 of EUR/USD at 1.08, EUR/AUD at 1.62 and EUR/ARS at 371, the Group expects for 2023:
- consolidated revenues of around €2,290 millions supported by continued market share gains, positive pricing actions and bolt-on acquisitions.
- Recurring EBITDA of around €550 million explained by the strong investments made in specialized field personnel (hearing care specialists) and marketing to support the Group's future growth path.
In the medium-term, the Group remains extremely positive on its prospects for sustainable growth in sales and profitability, thanks to the secular fundamentals of the hearing care market and its even stronger competitive positioning.
These expectations for 2023 do not include any further slowdowns in global economic activity due to, among others, the well-known inflation related issues and the ever-increasing uncertainties related to the current geopolitical situation. Toward this end, lastly, it should be noted that Amplifon operates around 25 points of sale in Israel which generate sales equal to approximately 1% of its consolidated revenues.
Milan, October 30th, 2023
CEO
Enrico Vita

Interim Financial Report as at 30 September 2023 > Interim Management Report
49

CONDENSED INTERIM CONSOLIDATED FINANCIAL
STATEMENTS AS AT 30 SEPTEMBER 2023

CONSOLIDATED STATEMENT OF FINANCIAL POSITION(*)
| (€ thousands) | 09/30/2023 | 12/31/2022 | Change | |
|---|---|---|---|---|
| ASSETS | ||||
| Non-current assets | ||||
| Goodwill | Note 3 | 40,295 | ||
| Intangible fixed assets with finite useful life | Note 4 | 425,164 | 420,098 | 5,066 |
| Property, plant, and equipment | Note 5 | 193,415 | 14,282 | |
| Right-of-use assets | Note 6 | 451,747 | 16,479 | |
| Equity-accounted investments | 2,293 | 2,093 | 200 | |
| Hedging instruments | 19,429 | 25,850 | (6,421) | |
| Deferred tax assets | 88,193 | 81,780 | 6,413 | |
| Contract costs | 12,583 | 11,131 | 1,452 | |
| Other assets | 46,577 | 42,470 | 4,107 | |
| Total non-current assets | 3,064,485 | 2,982,612 | 81,873 | |
| Current assets | ||||
| Inventories | 84,712 | 76,258 | 8,454 | |
| Trade receivables | 202,889 | 192,067 | 10,822 | |
| Contract costs | 4,900 | 5,262 | (362) | |
| Other receivables | 103,300 | 72,610 | 30,690 | |
| Hedging instruments | 218 | 17,016 | (16,798) | |
| Other financial assets | 51,021 | 49,986 | 1,035 | |
| Cash and cash equivalents | 146,767 | 179,654 | (32,887) | |
| Total current assets | 593,807 | 592,853 | 954 | |
| Total assets | 3,658,292 | 3,575,465 | 82,827 |

| (€ thousands) | 09/30/2023 | 12/31/2022 | Change | ||
|---|---|---|---|---|---|
| LIABILITIES | |||||
| Net Equity | |||||
| Share capital | Note 7 | 4,528 | 4,528 | - | |
| Share premium reserve | 202,712 | 202,712 | - | ||
| Treasury shares | (23,925) | (49,895) | 25,970 | ||
| Other reserves | (30,801) | 11,230 | (42,031) | ||
| Retained earnings | 813,818 | 691,409 | 122,409 | ||
| Profit (loss) for the period | 103,438 | 178,525 | (75,087) | ||
| Group net equity | 1,069,770 | 1,038,509 | 31,261 | ||
| Minority interests | 945 | 1,841 | (896) | ||
| Total net equity | 1,070,715 | 1,040,350 | 30,365 | ||
| Non-current liabilities | |||||
| Medium/long-term financial liabilities | Note 9 | 656,904 | 798,940 | (142,036) | |
| Lease liabilities | Note 11 | 368,890 | 10,636 | ||
| Provisions for risks and charges | Note 10 | 19,511 | 19,944 | (433) | |
| Liabilities for employees' benefits | 10,099 | 8,940 | 1,159 | ||
| Deferred tax liabilities | 105,897 | 106,683 | (786) | ||
| Payables for business acquisitions | 6,817 | 5,705 | 1,112 | ||
| Contract liabilities | 159,386 | 153,613 | 5,773 | ||
| Other long-term liabilities | 21,428 | 16,123 | 5,305 | ||
| Total non-current liabilities | 1,359,568 | 1,478,838 | (119,270) | ||
| Current liabilities | |||||
| Trade payables | 324,454 | 325,583 | (1,129) | ||
| Payables for business acquisitions | 9,357 | 24,601 | (15,244) | ||
| Contract liabilities | 112,637 | 114,857 | (2,220) | ||
| Tax liabilities | 69,048 | 74,785 | (5,737) | ||
| Other payables | 161,057 | 167,796 | (6,739) | ||
| Hedging instruments | 384 | - | 384 | ||
| Provisions for risks and charges | Note 10 | 975 | 1,663 | (688) | |
| Liabilities for employees' benefits | 3,368 | 3,616 | (248) | ||
| Short-term financial liabilities | Note 9 | 243,661 | 194,959 | ||
| Lease liabilities | Note 11 | 108,109 | 99,715 | 8,394 | |
| Total current liabilities | 1,228,009 | 1,056,277 | 171,732 | ||
| Total liabilities | 3,658,292 | 3,575,465 | 82,827 |
(*) Transactions with related parties have not been reported separately because not material both at single entity and at consolidated level. Please refer to note 17 for more details.

CONSOLIDATED INCOME STATEMENT(*)
| (€ thousands) | First nine months 2023 | First nine months 2022 | ||||||
|---|---|---|---|---|---|---|---|---|
| Recurring | Non recurring |
Total | Recurring | Non recurring |
Total | Change | ||
| Revenues from sales and services | Note 12 | 1,645,065 | - | 1,645,065 | 1,539,695 | - | 1,539,695 | 105,370 |
| Operating costs | Note 13 (1,263,004) | (13,221) | (1,276,225) | (1,175,114) | (5,630) | (1,180,744) | (95,481) | |
| Other income and costs | 3,745 | - | 3,745 | 4,949 | (51) | 4,898 | (1,153) | |
| Gross operating profit (EBITDA) | 385,806 | (13,221) | 372,585 | 369,530 | (5,681) | 363,849 | 8,736 | |
| Amortization, depreciation and impairment |
||||||||
| Amortization of intangible fixed assets with finite useful life |
Note 4 | (65,319) | - | (65,319) | (59,122) | - | (59,122) | (6,197) |
| Depreciation of property, plant, and equipment |
Note 5 | (39,486) | - | (39,486) | (37,894) | - | (37,894) | (1,592) |
| Right-of-use depreciation | Note 6 | (87,908) | - | (87,908) | (81,057) | - | (81,057) | (6,851) |
| Impairment losses and reversals of non-current assets |
(203) | - | (203) | (205) | - | (205) | 2 | |
| (192,916) | - | (192,916) | (178,278) | - | (178,278) | (14,638) | ||
| Operating result | 192,890 | (13,221) | 179,669 | 191,252 | (5,681) | 185,571 | (5,902) | |
| Financial income, expenses and value adjustments to financial assets Group's share of the result of associated companies valued at equity and gains/losses on disposals of equity investments |
210 | - | 210 | 323 | - | 323 | (113) | |
| Interest income and expenses | (19,036) | - | (19,036) | (13,923) | - | (13,923) | (5,113) | |
| Interest expenses on lease liabilities | (10,846) | - | (10,846) | (8,332) | - | (8,332) | (2,514) | |
| Other financial income and expenses | (3,528) | - | (3,528) | (1,728) | - | (1,728) | (1,800) | |
| Exchange gains and losses, and inflation accounting |
(4,438) | - | (4,438) | 651 | - | 651 | (5,089) | |
| Gain (loss) on assets accounted at fair value |
745 | - | 745 | (2,563) | - | (2,563) | 3,308 | |
| (36,893) | - | (36,893) | (25,572) | - | (25,572) | (11,321) | ||
| Profit (loss) before tax | 155,997 | (13,221) | 142,776 | 165,680 | (5,681) | 159,999 | (17,223) | |
| Current and deferred income tax | ||||||||
| Current tax | (50,062) | 3,844 | (46,218) | (59,179) | 1,588 | (57,591) | 11,373 | |
| Deferred tax | 6,883 | - | 6,883 | 13,302 | - | 13,302 | (6,419) | |
| (43,179) | 3,844 | (39,335) | (45,877) | 1,588 | (44,289) | 4,954 | ||
| Net profit (loss) | 112,818 | (9,377) | 103,441 | 119,803 | (4,093) | 115,710 | (12,269) | |
| Net profit (loss) attributable to Minority interests |
3 | - | 3 | 226 | - | 226 | (223) | |
| Net profit (loss) attributable to the Group |
112,815 | (9,377) | 103,438 | 119,577 | (4,093) | 115,484 | (12,046) |
(*) Transactions with related parties have not been reported separately because not material both at single entity and at consolidated level. Please refer to note 17 for more details.
| Earnings per share (€ per share) | First nine months | First nine months | ||
|---|---|---|---|---|
| Note 16 | 2023 | 2022 | ||
| Earnings per share - - |
Basic Diluted |
0.46166 0.49957 |
0.51488 0.50906 |

STATEMENT OF CONSOLIDATED COMPREHENSIVE INCOME
| (€ thousands) | First nine months 2023 |
First nine months 2022 |
|---|---|---|
| Net income (loss) for the period | 103,441 | 115,710 |
| Other comprehensive income (loss) that will not be reclassified subsequently to profit or loss: |
||
| Remeasurement of defined benefit plans | (943) | 9,704 |
| Tax effect on items of other comprehensive income (expense) that will not be reclassified subsequently to profit or loss |
201 | (1,821) |
| Total other comprehensive income (loss) that will not be reclassified subsequently to profit or loss after the tax effect (A) |
(742) | 7,883 |
| Other comprehensive income (loss) that will be reclassified subsequently to profit or loss | ||
| Gains/(losses) on cash flow hedging instruments | (6,694) | 23,498 |
| Gains/(losses) from Foreign Currency Basis Spread on hedging instruments | 516 | 1,031 |
| Gains/(losses) on exchange differences from translation of financial statements of foreign entities |
(41,167) | 36,980 |
| Tax effect on components of other comprehensive income that will be reclassified subsequently to profit or loss |
1,482 | (5,887) |
| Total other comprehensive income (loss) that will be reclassified subsequently to profit or loss after the tax effect (B) |
(45,863) | 55,622 |
| Total other comprehensive income (loss) (A)+(B) | (46,605) | 63,505 |
| Comprehensive income (loss) for the period | 56,836 | 179,215 |
| Attributable to the Group | 57,116 | 178,815 |
| Attributable to Minority interests | (280) | 400 |

STATEMENT OF CHANGES IN CONSOLIDATED EQUITY
| (€ thousands) | Share capital |
Share premium reserve |
Legal reserve |
Other reserves |
Treasury shares reserve |
Stock option and stock grant reserve |
|---|---|---|---|---|---|---|
| Balance at 1 January 2022 | 4,528 | 202,712 | 934 | 3,636 | (28,841) | 38,566 |
| Allocation of profit (loss) for 2021 | ||||||
| Share capital increase | ||||||
| Treasury shares | (42,872) | |||||
| Dividend distribution | ||||||
| Notional cost of stock grants | 12,819 | |||||
| Other changes | 25,140 | (12,711) | ||||
| - Stock Grant | 25,140 | (12,711) | ||||
| - Inflation accounting | ||||||
| - Other changes | ||||||
| Total comprehensive income (loss) for the period | ||||||
| - Hedge accounting | ||||||
| - Actuarial gains (losses) | ||||||
| - Translation differences | ||||||
| - Profit for the first nine months of 2022 | ||||||
| Balance at 30 September 2022 | 4,528 | 202,712 | 934 | 3,636 | (46,573) | 38,674 |
| (€ thousands) | Share capital | Share premium reserve |
Legal reserve |
Other reserves |
Treasury shares reserve |
Stock option and stock grant reserve |
|---|---|---|---|---|---|---|
| Balance at 1 January 2023 | 4,528 | 202,712 | 934 | 3,636 | (49,895) | 35,182 |
| Allocation of profit (loss) for 2022 | ||||||
| Share capital increase | ||||||
| Treasury shares | ||||||
| Dividend distribution | ||||||
| Notional cost of stock grants | 22,758 | |||||
| Other changes | 25,970 | (18,467) | ||||
| - Stock Grant | 25,970 | (18,467) | ||||
| - Inflation accounting | ||||||
| - Other changes | ||||||
| Total comprehensive income (loss) for the period |
||||||
| - Hedge accounting | ||||||
| - Actuarial gains (losses) | ||||||
| - Translation differences | ||||||
| - Profit for the first nine months of 2023 | ||||||
| Balance at 30 September 2023 | 4,528 | 202,712 | 934 | 3,636 | (23,925) | 39,473 |

| 16,825 | (209) | 873 | 688,853 | (2,566) | 115,484 | 1,023,171 | 2,267 | 1,025,438 |
|---|---|---|---|---|---|---|---|---|
| 115,484 | 115,484 | 226 | 115,710 | |||||
| 36,806 | 36,806 | 174 | 36,980 | |||||
| 7,883 | 7,883 | 7,883 | ||||||
| 17,858 | 784 | 18,642 | 18,642 | |||||
| 17,858 | 784 | 7,883 | 36,806 | 115,484 | 178,815 | 400 | 179,215 | |
| (538) | (538) | (236) | (774) | |||||
| 6,573 | 6,573 | 6,573 | ||||||
| (10,996) | 1,433 | 1,433 | ||||||
| (4,961) | 7,468 | (236) | 7,232 | |||||
| 12,819 | 12,819 | |||||||
| (58,237) | (58,237) | (58,237) | ||||||
| (42,872) | (42,872) | |||||||
| - | - | |||||||
| 157,785 | (157,785) | - | - | |||||
| (1,033) | (993) | (7,010) | 594,266 | (39,372) | 157,785 | 925,178 | 2,103 | 927,281 |
| Cash flow hedge reserve |
Foreign Curr. Basis Spread Reserve |
Actuarial gains and losses |
Retained earnings |
Translation differences |
Profit (loss) for the period |
Total Shareholders' equity |
Minority interests |
Total net equity |
| Total net equity |
Minority interests |
Total Shareholders' equity |
Profit (loss) for the period |
Translation differences |
Retained earnings |
Actuarial gains and losses |
Foreign Curr. Basis Spread Reserve |
Cash flow hedge reserve |
|---|---|---|---|---|---|---|---|---|
| 1,040,350 | 1,841 | 1,038,509 | 178,525 | (50,825) | 691,409 | 2,782 | (392) | 19,913 |
| - | - | (178,525) | 178,525 | |||||
| - | - | |||||||
| - | - | |||||||
| (65,361) | (65,361) | (65,361) | ||||||
| 22,758 | 22,758 | |||||||
| 16,132 | (616) | 16,748 | 9,245 | |||||
| 3,365 | 3,365 | (4,138) | ||||||
| 14,429 | 14,429 | 14,429 | ||||||
| (1,662) | (616) | (1,046) | (1,046) | |||||
| 56,836 | (280) | 57,116 | 103,438 | (40,884) | (742) | 392 | (5,088) | |
| (4,696) | (4,696) | 392 | (5,088) | |||||
| (742) | (742) | (742) | ||||||
| (41,167) | (283) | (40,884) | (40,884) | |||||
| 103,441 | 3 | 103,438 | 103,438 | |||||
| 1,070,715 | 945 | 1,069,770 | 103,438 | (91,709) | 813,818 | 2,040 | - | 14,825 |

STATEMENT OF CONSOLIDATED CASH FLOWS
| First nine months | First nine months | |
|---|---|---|
| (€ thousands) | 2023 | 2022 |
| OPERATING ACTIVITIES | ||
| Net profit (loss) | 103,441 | 115,710 |
| Amortization, depreciation and impairment: | ||
| - intangible fixed assets | 65,345 | 59,096 |
| - tangible fixed assets | 39,663 | 38,124 |
| - right-of-use assets | 87,908 | 81,057 |
| Provisions, other non-monetary items and gain/losses from disposals | 28,735 | 15,826 |
| Group's share of the result of associated companies | (207) | (322) |
| Financial income and expenses | 37,102 | 25,894 |
| Current and deferred taxes | 39,333 | 44,289 |
| Cash flow from operating activities before change in working capital | 401,320 | 379,674 |
| Utilization of provisions | (7,356) | (7,726) |
| (Increase) decrease in inventories | (8,505) | (8,900) |
| Decrease (increase) in trade receivables | (14,469) | (3,949) |
| Increase (decrease) in trade payables | 3,011 | 36,111 |
| Changes in other receivables and other payables | (25,651) | (40,865) |
| Total change in assets and liabilities | (52,970) | (25,329) |
| Dividends received | 3 | 342 |
| Interest received (paid) | (34,120) | (23,893) |
| Taxes paid | (60,679) | (33,047) |
| Cash flow generated from (absorbed by) operating activities (A) | 253,554 | 297,747 |
| INVESTING ACTIVITIES: | ||
| Purchase of intangible fixed assets | (51,313) | (37,172) |
| Purchase of tangible fixed assets | (50,347) | (43,093) |
| Consideration from sale of non-current assets | 1,827 | 4,902 |
| Cash flow generated from (absorbed by) operating investing activities (B) | (99,833) | (75,363) |
| Purchase of subsidiaries and business units net of cash and cash equivalents acquired or | ||
| dismissed | (83,243) | (52,243) |
| Increase (decrease) in payables for business acquisitions | (13,993) | (7,719) |
| Cash flow generated from (absorbed by) acquisition activities (C) | (97,236) | (59,962) |
| Cash flow generated from (absorbed by) investing activities (B+C) | (197,069) | (135,325) |
| FINANCING ACTIVITIES: | ||
| Increase (decrease) in financial payables | 67,953 | (85,315) |
| (Increase) decrease in financial receivables | (829) | (57) |
| Principal portion of lease payments | (85,095) | (80,125) |
| Hedging instruments | (1,483) | - |
| Fees paid on long-term borrowings | (1,413) | - |
| Other non-current assets and liabilities | (982) | 904 |
| Dividend distributed | (65,361) | (58,237) |
| Treasury shares purchase | - | (42,872) |
| Capital increases and minority shareholders' contributions and dividends paid to third parties by subsidiaries |
(137) | (608) |
| Cash flow generated from (absorbed by) financing activities (D) | (87,347) | (266,310) |
| Net increase in cash and cash equivalents (A+B+C+D) | (30,862) | (103,888) |

| First nine months | First nine months | |
|---|---|---|
| (€ thousands) | 2023 | 2022 |
| Cash and cash equivalents at beginning of period | 179,654 | 268,546 |
| Effect of exchange rate fluctuations on cash & cash equivalents | (2,025) | 3,798 |
| Flows of cash and cash equivalents | (30,862) | (103,888) |
| Cash and cash equivalents at end of period | 146,767 | 168,456 |
Related-party transactions relate to lease of the main office and certain stores, to recharges of maintenance costs and general services of the above-mentioned buildings and to commercial transactions, personnel costs and loans. Such operations are detailed in Note 17.
SUPPLEMENTARY INFORMATION TO THE STATEMENT OF CONSOLIDATED CASH FLOWS
The fair values of the assets and liabilities acquired are summarized in the table below:
| (€ thousands) | First nine months 2023 |
First nine months 2022 |
|---|---|---|
| - Goodwill | 63,481 | 41,867 |
| - Customer lists | 22,897 | 17,025 |
| - Trademarks, licenses, and non-competition agreements | 1 | 80 |
| - Other intangible fixed assets with finite useful life | 502 | 212 |
| - Property, plant, and equipment | 4,979 | 1,637 |
| - Right-of-use assets | 938 | 1,822 |
| - Current assets | 6,189 | 4,372 |
| - Provision for risk and charges | 3 | - |
| - Current liabilities | (8,348) | (5,928) |
| - Other non-current assets and liabilities | (6,172) | (6,849) |
| - Third parties equity | 1,645 | - |
| Total investments | 86,115 | 54,238 |
| Net financial debt acquired | 976 | 641 |
| Total business combinations | 87,091 | 54,879 |
| (Increase) decrease in payables through business acquisition | 13,993 | 7,719 |
| Purchase (sale) of other investments and securities | - | - |
| Cash flow absorbed by (generated from) acquisitions | 101,084 | 62,598 |
| (Cash and cash equivalents acquired) | (3,848) | (2,636) |
| Net cash flow absorbed by (generated from) acquisitions | 97,236 | 59,962 |

NOTES
1. General information
The Amplifon Group is global leader in the distribution of hearing solutions and the fitting of customized products.
The parent company, Amplifon S.p.A. is based in Via Ripamonti 133, Milan, Italy. The Group is controlled directly by Ampliter S.r.l. (42.12% as at 30 September 2023), held for a 100% by Amplifin S.p.A., which is 99.4% owned by Susan Carol Holland and the remaining 0.6% in treasury shares.
The condensed interim consolidated financial report as at 30 September 2023 was prepared in accordance with International Accounting Standards, as well as the implementation regulations set out in Article 9 of Legislative Decree no. 38 of 28 February 2005. These standards include the IAS and IFRS issued by the International Accounting Standard Board, as well as the SIC and IFRIC interpretations issued by the International Financial Reporting Interpretations Committee, which were endorsed in accordance with the procedure set out in Article 6 of Regulation (EC) no. 1606 of 19 July 2002 by 30 September 2023. The International Accounting Standards endorsed after that date and before the preparation of this report were adopted in the preparation of the condensed interim consolidated financial report only if early adoption is allowed by the Endorsing Regulation and the standard itself and if the Group had elected to do so.
The condensed interim consolidated financial statements at 30 September 2023 do not include all the additional information required by the annual financial statements and must be read together with the annual consolidated financial statements of the Group at 31 December 2022.
The publication of the condensed interim consolidated financial statements of the Amplifon Group at 30 September 2023 was authorized by a resolution of the Board of Directors of 30 October 2023 which approved their publication.
According to the Consob Communication of 28 July 2006, it is specified that during the nine months of 2023 the Group did not carry out atypical and/or unusual transactions, as defined by the Communication itself.

2. Impact of the conflict in Ukraine, in Middle East, and climate change on the Group's performance and financial position
The Group has no business activities, direct or indirect, in either Ukraine, Russia or Belarus and limited activities in surrounding countries. The military conflict in Ukraine, therefore, has not yet had any direct impact on the Group's performance or business. That said, in 2022 the Russian-Ukrainian conflict caused a strong increase in inflation worldwide causing the central banks to tighten monetary policies and raise interest rates which stabilized somewhat in the first nine months of 2023 but, however, continue to be very high. The economic recovery that characterized the first postpandemic phase slowed rapidly and the short/medium-term prospects remain uncertain and hard to assess with the possibility that an economic recession may materialize or persist. With regard to the conflict in the Middle East, the Amplifon Group has around 25 points of sale in Israel which generate sales equal to approximately 1% of annual consolidated revenues.
While the hearing aid market has always proven to be resilient even in times of economic crisis, as hearing solutions and services are non-discretional products which benefit people's physical, emotional and relational health significantly, and customers are assisted by public and private insurances, as well as consumer loans, the current inflationary environment and uncertainty about the future costs of basic necessities could cause a few potential customers to postpone the purchase of a hearing aid temporarily, particularly if needed in the medium-term. Although the Group monitors the changing macroeconomic environment and the relative impact on the business constantly, it cannot be excluded that the situation described above could cause the demand for the Group's services and products to slow even though, as mentioned before, Amplifon operates in a market segment which in the past, albeit in situations that are not directly comparable, has proven to be less sensitive than others to changes in the general economic cycle.
With regard to climate change, the Group's business model is based on providing retail hearing solutions. The goals, therefore, connected to transitioning to alternative sources of energy and the actions needed to address climate change are pursued thanks to the steps taken by the Group to improve the energy efficiency of its business activities, as well as report on the greenhouse gas emissions generated along the value chain. Moreover, the Group's activities and business model do not entail significant exposure to the environmental risks connected specifically to climate change.

3. Acquisitions and goodwill
In the first nine months of 2023 the Group continued with its strategy to balance external and internal growth and acquired 219 points of sale, comprising 93 in Asia Pacific, 61 in EMEA and 65 in Americas.
The total investment, including the indebtedness consolidated and the best estimate of the net change in the earn-out linked to sales and profitability targets payable over the next few years, amounted to €83,243 thousand.
The changes in goodwill and amounts recognized as a result of the acquisitions made in the period are reported in the table below and shown by groups of Cash Generating Units.
| (€ thousands) | Net carry at 12/31/2022 |
Business combinations completed in the reporting period |
Disposals | Impairment | Other net changes | Net carry at 09/30/2023 |
|---|---|---|---|---|---|---|
| EMEA | 921,163 | 24,087 | - | - | 75 | 945,325 |
| AMERICAS | 213,816 | 31,573 | - | - | 1,822 | 247,211 |
| APAC | 619,049 | 7,821 | - | - | (25,083) | 601,787 |
| Total | 1,754,028 | 63,481 | - | - | (23,186) | 1,794,323 |
"Acquisitions in the period" refers to the temporary allocation to goodwill of the portion of the purchase price paid, including deferments and contingent consideration (earn-outs), which is not directly attributable to the fair value of assets and liabilities, but is based on the positive contribution to cash flows that is expected to be made for an indefinite period of time. "Other net changes" refers almost entirely to foreign exchange differences.
Identification of the Groups of Cash Generating Units
For the purposes of impairment testing the total goodwill stemming from the cost incurred for a business combination was allocated to groups of Cash Generating Units; these groups of Cash Generating Units were identified by region and benefit from synergies, as well as shared policies, and are autonomous in the management and use of resources.
The assets allocated to the groups of Cash Generating Units and the methods used to determine these groups are the same as those applied to the financial Statements as at 31 December 2022.
The groups of Cash Generating Units recognized are:
- EMEA which includes Italy, France, the Netherlands, Germany, Belgium, Switzerland, Spain, Portugal, the UK, Hungary, Poland, Israel and Egypt;
- AMERICAS which includes both the single businesses through which operations are carried out in the US market (Franchising, Retail and Managed Care) and the countries (Canada, Argentina, Chile, Mexico, Panama, Ecuador and Colombia);
- ASIA PACIFIC which includes Australia, New Zealand, India and China.

The recoverable value of goodwill is determined based on the value in use or, if the latter is less than book value, on fair value. As at 31 December 2022 the management's valuations were made taking into consideration the value in use. No loss in value was identified as a result of the impairment tests conducted at 31 December 2022.
The Group tests for impairment of goodwill once a year and in the event of any impairment indicators.
In the first nine months of 2023 the Group's turnover was higher than both the comparison period and the budget. EBITDA was also higher than in the prior year and basically in line with the budget. In terms of regions, at constant exchange rates EBITDA was below budget by 3.8% and 4.3% in EMEA and APAC, respectively, but higher in Americas and for Corporate.
The impairment tests conducted at 31 December 2022 showed there was enough headroom to absorb the under-budget cash flow, much ampler than any gap recorded in the single regions in the first nine months.
The Equity risk premium was, furthermore, down one percentage point (Source: Damodaran) and the long-term risk-free interest rate was slightly higher than the rate used in the impairment tests at 31 December 2022. The WACC discount rate at 30 September was lower than the rate used at 31 December 2022 for all the groups of Cash Generating Units which had headroom to absorb any future increases in rates of between 2% and 16%.
The future growth rates measured at 30 September 2023 were largely in line with the rate used for the purposes of the impairment tests at 31 December 2022, which indicates significant headroom for any decreases in the rate of between -2% and -27%.
Based on the above:
- revenues higher with respect to 2022 and the budget, EBITDA slightly under budget in the regions (mainly EMEA and APAC) fully absorbed by the ample headroom found based on the impairment test at 31 December 2022;
- the discount rate (WACC) redetermined at 30 September 2023 is lower than the rate used in the impairment tests conducted at 31 December 2022;
- the growth rates redetermined at 30 September 2023 are slightly higher than the ones used in the impairments tests conducted at 31 December 2022.
No indicators of impairment, therefore, emerged and no specific impairment tests were made. For the purposes of measuring the recoverable value of goodwill reference should be made to the impairment tests reported on in the Annual Report 2022.
The budget/business plan 2024-2026 is in the process of being finalized and, as usual, will be the basis for the 2023 annual impairment tests.

A summary of the book value and the fair value of assets and liabilities, deriving from the temporary allocation of the purchase price made as a result of business combinations and the purchase of minority interests in subsidiaries, is provided in the following table.
| (€ thousands) | EMEA | Americas | APAC | Total |
|---|---|---|---|---|
| Cost of acquisitions of the period | 33,299 | 34,589 | 18,227 | 86,115 |
| Assets and liabilities acquired – Book value | ||||
| Current assets | 848 | 1,492 | - | 2,340 |
| Current liabilities | (2,447) | (2,149) | - | (4,596) |
| Net working capital | (1,599) | (657) | - | (2,256) |
| Other intangible, tangible and right-of-use assets | 2,655 | 1,176 | 2,590 | 6,421 |
| Provision for risk and charges | 3 | - | - | 3 |
| Other non-current assets and liabilities | (846) | 43 | - | (803) |
| Non-current assets and liabilities | 1,812 | 1,219 | 2,590 | 5,621 |
| Net invested capital | 213 | 562 | 2,590 | 3,365 |
| Third Parties Equity | - | 1,645 | - | 1,645 |
| Net financial position | 2,736 | 136 | - | 2,872 |
| NET EQUITY ACQUIRED - BOOK VALUE | 2,949 | 2,343 | 2,590 | 7,882 |
| DIFFERENCE TO BE ALLOCATED | 30,350 | 32,246 | 15,637 | 78,233 |
| ALLOCATIONS | ||||
| Customer lists | 11,837 | 3,243 | 7,816 | 22,896 |
| Contract liabilities - Short and long-term | (3,911) | (2,570) | - | (6,481) |
| Deferred tax assets | 286 | - | - | 286 |
| Deferred tax liabilities | (1,949) | - | - | (1,949) |
| Total allocations | 6,263 | 673 | 7,816 | 14,752 |
| GOODWILL | 24,087 | 31,573 | 7,821 | 63,481 |

4. Intangible fixed assets with finite useful life
The following table shows the changes in intangible assets.
| (€ thousands) | Historical cost at 12/31/2022 |
Accumulated amortization and write downs at 12/31/2022 |
Net book value at 12/31/2022 |
Historical cost at 09/30/2023 |
Accumulated amortization and write downs at 09/30/2023 |
Net book value at 09/30/2023 |
|---|---|---|---|---|---|---|
| Software | 235,964 | (143,068) | 92,896 | 248,928 | (162,440) | 86,488 |
| Licenses | 23,024 | (18,450) | 4,574 | 27,489 | (18,422) | 9,067 |
| Non-competition agreements | 14,328 | (7,749) | 6,579 | 19,313 | (13,884) | 5,429 |
| Customer lists | 464,959 | (258,275) | 206,684 | 467,697 | (267,371) | 200,326 |
| Trademarks and concessions | 96,559 | (44,113) | 52,446 | 94,847 | (48,761) | 46,086 |
| Other | 22,665 | (11,292) | 11,373 | 13,945 | (4,066) | 9,879 |
| Fixed assets in progress and advances |
45,546 | - | 45,546 | 67,889 | - | 67,889 |
| Total | 903,045 | (482,947) | 420,098 | 940,108 | (514,944) | 425,164 |
| (€ thousands) | Net book value at 12/31/2022 |
Investments | Disposals | Amortization | Business combinations |
Impairment | Other net changes |
Net book value at 09/30/2023 |
|---|---|---|---|---|---|---|---|---|
| Software | 92,896 | 10,466 | (546) | (24,482) | 3 | - | 8,151 | 86,488 |
| Licenses | 4,574 | 7,063 | (593) | (3,715) | 1 | - | 1,737 | 9,067 |
| Non-competition agreements |
6,579 | 1,322 | - | (3,066) | - | - | 594 | 5,429 |
| Customer lists | 206,684 | 19 | - | (27,735) | 22,897 | - | (1,539) | 200,326 |
| Trademarks and concessions |
52,446 | - | - | (5,761) | 4 | (11) | (592) | 46,086 |
| Other | 11,373 | 338 | (268) | (560) | - | (15) | (989) | 9,879 |
| Fixed assets in progress and advances |
45,546 | 32,105 | 763 | - | 495 | - | (11,020) | 67,889 |
| Total | 420,098 | 51,313 | (644) | (65,319) | 23,400 | (26) | (3,658) | 425,164 |
The investments in intangible fixed assets with finite useful life recorded in the reporting period (€51,313 thousand) are attributable to the new front office solutions and the AI technologies used to provide customers with a highly personalized experience, and the ongoing implementation and standardization of the Group cloud-based ERP system for back-office functions (HR, Procurement, Administration and Finance).
The change in "Business combinations" comprises:
- For €11,846 thousand, the temporary allocation of the price paid for acquisitions made in EMEA;
- For €3,738 thousand, the temporary allocation of the price paid for acquisitions made in Americas;
- For €7,816 thousand, the temporary allocation of the price paid for acquisitions made in APAC.

The item "Other net changes" is explained almost entirely by foreign exchange differences and the reclassification of work in progress completed in the period.
5. Property, plant, and equipment
The following table shows the changes in property, plant, and equipment.
| (€ thousands) | Historical cost at 12/31/2022 |
Accumulated amortization and write downs at 12/31/2022 |
Net book value at 12/31/2022 |
Historical cost at 09/30/2023 |
Accumulated amortization and write downs at 09/30/2023 |
Net book value at 09/30/2023 |
|---|---|---|---|---|---|---|
| Land | 154 | - | 154 | 154 | - | 154 |
| Buildings, constructions and leasehold improvements |
298,991 | (199,083) | 99,908 | 313,814 | (213,262) | 100,552 |
| Plant and machines | 52,414 | (42,077) | 10,337 | 42,321 | (33,825) | 8,496 |
| Industrial and commercial equipment |
76,808 | (58,052) | 18,756 | 89,972 | (70,604) | 19,368 |
| Motor vehicles | 1,047 | (776) | 271 | 1,110 | (813) | 297 |
| Computers and office machinery |
80,108 | (62,712) | 17,396 | 84,413 | (66,585) | 17,828 |
| Furniture and fittings | 124,155 | (91,452) | 32,703 | 129,974 | (97,128) | 32,846 |
| Other tangible fixed assets | 5,673 | (3,031) | 2,642 | 6,949 | (4,503) | 2,446 |
| Fixed assets in progress and advances |
11,248 | - | 11,248 | 25,710 | - | 25,710 |
| Total | 650,598 | (457,183) | 193,415 | 694,417 | (486,720) | 207,697 |
| (€ thousands) | Net book value at 12/31/2022 |
Investments | Disposals | Amortization | Business combinations |
Impairment | Other net changes |
Net book value at 09/30/2023 |
|---|---|---|---|---|---|---|---|---|
| Land | 154 | - | - | - | - | - | - | 154 |
| Buildings, constructions and leasehold improvements |
99,908 | 16,700 | (262) | (18,758) | 125 | (88) | 2,927 | 100,552 |
| Plant and machines | 10,337 | 1,436 | - | (2,198) | 376 | (75) | (1,380) | 8,496 |
| Industrial and commercial equipment |
18,756 | 3,623 | (291) | (4,802) | 131 | (5) | 1,956 | 19,368 |
| Motor vehicles | 271 | 113 | (42) | (72) | 24 | 1 | 2 | 297 |
| Computers and office machinery |
17,396 | 4,144 | (40) | (6,074) | 1,523 | - | 879 | 17,828 |
| Furniture and fittings | 32,703 | 5,504 | (88) | (7,083) | 1,266 | (13) | 557 | 32,846 |
| Other tangible fixed assets | 2,642 | 118 | (1) | (499) | 1 | - | 185 | 2,446 |
| Fixed assets in progress and advances |
11,248 | 18,709 | (121) | - | 1,533 | 3 | (5,662) | 25,710 |
| Total | 193,415 | 50,347 | (845) | (39,486) | 4,979 | (177) | (536) | 207,697 |
The investments made in the reporting period (€50,347 thousand) refer primarily to the network expansion with the opening of new stores and renewal of existing ones, as well as to the purchase of hardware needed for the implementation of Group Information Technology projects.

The change in "business combinations" comprises:
- for €1,740 thousand, the temporary allocation of the price paid for acquisitions made in EMEA;
- for €649 thousand, the temporary allocation of the price paid for acquisitions made in Americas;
- for €2,590 thousand, the temporary allocation of the price paid for acquisitions made in APAC.
"Other net changes" is explained primarily by foreign exchange differences recorded in the reporting period and the reclassification of work in progress completed in the period.
6. Right-of-use assets
Right-of-use assets are reported here below:
| (€ thousands) | Historical cost at 12/31/2022 |
Accumulated amortization and write downs at 12/31/2022 |
Net book value at 12/31/2022 |
Historical cost at 09/30/2023 |
Accumulated amortization and write downs at 09/30/2023 |
Net book value at 09/30/2023 |
||
|---|---|---|---|---|---|---|---|---|
| Stores and offices | 777,889 | (336,445) | 441,444 | 846,541 | (392,500) | 454,041 | ||
| Motor vehicles | 24,819 | (15,365) | 9,454 | 29,675 | (17,749) | 11,926 | ||
| Electronic machinery | 1,657 | (808) | 849 | 3,619 | (1,360) | 2,259 | ||
| Total | 804,365 | (352,618) | 451,747 | 879,835 | (411,609) | 468,226 | ||
| (€ thousands) | Net book value at 12/31/2022 |
Increase | Decrease | Depreciation | Business combinations |
Impairment | Other net changes |
Net book value at 09/30/2023 |
| Stores and offices | 441,444 | 95,608 | (4,465) | (82,821) | 938 | - | 3,337 | 454,041 |
| Motor vehicles | 9,454 | 6,415 | 209 | (4,412) | - | - | 260 | 11,926 |
| Electronic machinery | 849 | 2,089 | - | (675) | - | - | (4) | 2,259 |
| Total | 451,747 | 104,112 | (4,256) | (87,908) | 938 | - | 3,593 | 468,226 |
The increase in right of use assets acquired in the period (€104,112 thousand) is explained by the renewal of existing leases and the network expansion.
The change in "business combinations" comprises:
- for €906 thousand, the temporary allocation of the price paid for acquisitions made in EMEA;
- for €32 thousand, the temporary allocation of the price paid for acquisitions made in Americas;
"Other changes" refers mainly to foreign exchange differences recorded in the reporting period.

7. Share capital
On 30 September 2023 the share capital comprised 226,388,620 ordinary shares with a par value of €0.02 fully paid in and subscribed, unchanged concerning 31 December 2022.
A total of 953,227 of the performance stock grant rights were exercised in the period, as a result of which the Group transferred the same number of treasury shares to the beneficiaries.
A total of 878,133 treasury shares, or 0.388% of the parent's share capital, were held at 30 September 2023.
Information relating to the treasury shares held is shown below:
| Average purchase price (Euro) | Total amount (€ thousands) |
|||
|---|---|---|---|---|
| No. of shares | FV of transferred rights (Euro) | |||
| Held at 12/31/2022 | 1,831,360 | 27.245 | 49,895 | |
| Transfers due to exercise of performance stock grants | (953,227) | 27.245 | (25,970) | |
| Held at 09/30/2023 | 878,133 | 27.245 | 23,925 |

8. Net financial position
The Group's net financial position, including lease liabilities, prepared in accordance with the ESMA guideline 32-382-1138 of 4 March 2021 and CONSOB's Warning Notice n. 5/21 of 29 April 2021, is shown below.
| (€ thousands) | 09/30/2023 | 12/31/2022 | Change |
|---|---|---|---|
| Cash (A) | 146,767 | 179,654 | (32,887) |
| Cash equivalents (B) | - | - | - |
| Short term investments (C) | 51,003 | 49,968 | 1,035 |
| Total Cash, Cash Equivalents and Short-Term Investments (A+B+C) (D) |
197,770 | 229,622 | (31,852) |
| Current financial payables (including bonds, but excluding current portion of medium/long-term debt) (E) |
433,219 | 221,095 | 212,124 |
| - Bank borrowings | 197,487 | 116,659 | 80,828 |
| - Private Placement 2013-2025 | - | 103,131 | (103,131) |
| - Other financial payables and bank overdrafts | 235,565 | 19,697 | 215,868 |
| - Hedging derivatives | 167 | (18,392) | 18,559 |
| Current portion of medium/long-term financial debt (F) | 124,311 | 130,329 | (6,018) |
| - Financial accruals and deferred income | 6,845 | 6,012 | 833 |
| - Payables for business acquisitions | 9,357 | 24,601 | (15,244) |
| - Lease Liability – current portion | 108,109 | 99,716 | 8,393 |
| Current Financial Indebtedness (E+F) (G) | 557,530 | 351,424 | 206,106 |
| Net Current Financial Indebtedness (G-D) (H) | 359,760 | 121,802 | 237,958 |
| Non current financial payables (I) | 695,508 | 826,797 | (131,289) |
| - Bank borrowings – Non current portion | 309,165 | 452,202 | (143,037) |
| - Payables for business acquisitions – Non current portion | 6,817 | 5,705 | 1,112 |
| - Lease Liability – Non current portion | 379,526 | 368,890 | 10,636 |
| Bonds (J) | 350,000 | 350,000 | - |
| - Eurobond 2020-2027 | 350,000 | 350,000 | - |
| Trade and other non current payables (K) | - | - | - |
| - Hedging derivatives – non current portion | - | - | - |
| Non Current Financial Indebtedness (I+J+K) (L) | 1,045,508 | 1,176,797 | (131,289) |

Excluding lease liabilities (€487,635 thousand at 30 September 2023), net financial debt amounted to €917,633 thousand at 30 September 2023, broken down as follows:
| (€ thousands) | 09/30/2023 | 12/31/2022 | Change |
|---|---|---|---|
| Cash and Cash Equivalents | 146,767 | 179,654 | (32,887) |
| Short Term Investments | 51,003 | 49,968 | 1,035 |
| Cash, Cash Equivalents and Short Term Investments | 197,770 | 229,622 | (31,852) |
| Current Financial Indebtedness (excluding lease liabilities) |
449,421 | 251,708 | 197,713 |
| Net Current Financial Indebtedness (excluding lease liabilities) |
251,651 | 22,086 | 229,565 |
| Non current Financial Indebtedness (excluding lease liabilities) |
665,982 | 807,907 | (141,925) |
| Total Financial Indebtedness (excluding lease liabilities) | 917,633 | 829,993 | 87,640 |
At the end of January 2023, the entire Private Placement 2013-2025 was repaid in advance (€85,371 thousand at the hedging rate). The subsequent elimination of the relative financial covenants allowed the Group to further increase its financial flexibility, as well as reduce the total cost of funding.
At the end of May 2023, a new €300 million sustainability-linked revolving line of credit was obtained from a pool of banks. This new facility, with a 3-year term and an extension option for 2 additional years at the Company's discretion, provides Amplifon with greater financial flexibility, further strengthening its solid liquidity position, diversifying the sources of funding and extending the average debt maturity. In July 2023 Amplifon signed a €300 million loan agreement with the European Investment Bank (EIB) to finance its innovation and digitalization process (out of a total of €350 million in financing approved by the EIB). The loan, unutilized at the end of September 2023, will contribute to the further innovation of Amplifon's products and services, providing an excellent and highly personalized hearing care experience thanks to the use of a full ecosystem built around the customer, in which the quantity and quality of the Company's services, as well as digital technologies, play a key role.
Long-term net financial debt, excluding lease liabilities, amounted to €665,982 thousand at 30 September 2023 and to €807,907 thousand at 31 December 2022. The decrease of €141,925 thousand is attributable mainly to the reclassification of portions of long-term bank debt, expiring in the next 12 months, from long-to short-term.
The short-term portion of net financial debt, excluding lease liabilities, increased by €229,565 thousand, going from €22,086 thousand at 31 December 2022 to €251,651 thousand at 30 September 2023 due to the repayments of the short-term portion of long-term debt made using the short-term credit lines. The portions of long-term debt maturing in the next 12 months and the other short-term components of financial debt exceed available liquidity, other cash equivalents and other short-term liquid assets. The Group, however, has unutilized, irrevocable lines of credit of €555 million which, in addition to the €42 million in available uncommitted

credit lines and the cash generation expected for the fourth quarter of 2023, ensure enough liquidity to satisfy current obligations and support business needs.
More specifically, the short-term portion of the net financial position includes the short-term portion of long-term bank loans (€197,487 thousand), other bank debt of €235,281 thousand including hot money and utilization of short-term credit lines, interest payable on the Eurobond (€2,470 thousand), as well as on other bank borrowings (€3,944 thousand), and lastly, the best estimate of the deferred payments for acquisitions (€9,357 thousand), net of the €197,770 thousand in liquidity. Liquidity includes €146,767 thousand in available cash and €51,003 thousand in other financial assets that are easily liquidated. These financial assets refer to investments made in money market funds managed by top-tier financial institutions.
Bank loans, and the Eurobond 2020-2027 are included in the statement of financial position as follows:
a. under the item "medium/long-term financial liabilities".
| (€ thousands) | Balance at 09/30/2023 |
|---|---|
| Eurobond 2020-2027 | 350,000 |
| Other medium/long-term debt | 309,165 |
| Fees on Eurobond 2020-2027 and bank loans | (2,261) |
| Medium/long-term financial liabilities | 656,904 |
b. under the item "financial payables (current)".
| (€ thousands) | Balance at 09/30/2023 |
|---|---|
| Bank overdraft and other short-term debt (including current portion of other long-term debt) | 432,962 |
| Other financial payables | 6,845 |
| Fees on bank loans | (1,187) |
| Short-term financial liabilities | 438,620 |
All the other items in the net financial position table can be easily referred to in the financial consolidated statements.

9. Financial liabilities
The financial liabilities breakdown is as follows:
| (€ thousands) | Balance at 09/30/2023 |
Balance at 12/31/2022 |
Change |
|---|---|---|---|
| Eurobond 2020-2027 | 350,000 | 350,000 | - |
| Other medium long-term bank loans | 309,165 | 452,202 | (143,037) |
| Fees on Eurobond 2020-2027, bank loans, and private placement 2013-2025 | (2,261) | (3,262) | 1,001 |
| Total medium/long-term financial liabilities | 656,904 | 798,940 | (142,036) |
| Short term debt | 438,620 | 243,661 | 194,959 |
| - of which current portion of short-term bank loans | 197,487 | 116,659 | 80,828 |
| - of which current portion of private placement 2013-2025 | - | 103,131 | (103,131) |
| - of which debts for account overdrafts and other short-term liabilities | 235,191 | 18,212 | 216,979 |
| - of which fees for bank loans and private placement 2013-2025 | (1,187) | (1,245) | 58 |
| Total short-term financial liabilities | 438,620 | 243,661 | 194,959 |
| Total financial liabilities | 1,095,524 | 1,042,601 | 52,923 |
The main financial liabilities are detailed below.
- Eurobond 2020-2027
This is a €350,000 thousand 7-year non-convertible bond with a fixed annual coupon of 1.125% that is listed on the Luxembourg Stock Exchange's unregulated market.
| Issue Date | Debtor | Maturity | Nominal value (€/000) |
Fair Value (€/000) |
Nominal interest rate (*) |
Euro interest rate after hedging |
|---|---|---|---|---|---|---|
| 02/13/2020 | Amplifon S.p.A. | 02/13/2027 | 350,000 | 315,377 | 1.125% | N/A |
| Total in Euro | 350,000 | 315,377 |
(*) The nominal interest rate is equal to the mid swap plus a spread.

- Bank loans
These are the main bilateral and pooled loans which are detailed below:
| Issue Date | Debtor | Type | Maturity | Nominal value (€/000) |
Outstanding debt (€/000) |
Fair Value (€/000) |
Nominal interest rate (*) |
Hedged nominal amount (**) |
Interest rate after hedging (**) |
|---|---|---|---|---|---|---|---|---|---|
| 04/07/2020 | Amplifon S.p.A. | Bullet | 03/22/2024 | 60,000 | 60,000 | 61,275 | 5.380% | ||
| 04/06/2020 | Amplifon S.p.A. | Amortizing | 04/06/2025 | 50,000 | 28,571 | 28,814 | 4.302% | 28,571 | 0.880% |
| 04/07/2020 | Amplifon S.p.A. | Amortizing | 04/07/2025 | 150,000 | 105,000 | 106,673 | 4.406% | 70,000 | 2.17% |
| 04/28/2020 | Amplifon S.p.A. | Amortizing | 04/28/2025 | 50,000 | 50,000 | 51,443 | 4.698% | ||
| 04/29/2020 | Amplifon S.p.A. | Amortizing | 04/29/2025 | 78,000 | 39,000 | 39,621 | 4.865% | 27,300 | 2.450% |
| 04/23/2020 | Amplifon S.p.A. | Amortizing | 06/30/2025 | 35,000 | 27,125 | 27,400 | 3.826% | 27,125 | 0.785% |
| 08/03/2020 | Amplifon S.p.A. | Amortizing | 06/30/2025 | 10,000 | 3,559 | 3,597 | 5.005% | ||
| 12/23/2021 | Amplifon S.p.A. | Amortizing | 12/23/2026 | 210,000 | 193,200 | 212,154 | 4.730% | 193,200 | 1.163% |
| Total | 643,000 | 506,455 | 530,977 | 346,196 |
(*) The nominal interest rate comprises the benchmark rate (Euribor) plus the applicable spread.
(**) An Interest Rate Swap was used to hedge these loans against interest rate risk at the IRS rate plus a spread.
Group's loans, bonds, and revolving credit lines are subject to the following financial covenants:
- the net financial indebtedness, excluding lease liabilities, to Group net equity (Net Worth Ratio) must not exceed 1.65;
- the Leverage Ratio, calculated as the ratio of net financial debt, excluding lease liabilities, to EBITDA recorded in the last four quarters (determined excluding the fair value of the stock-based payments, based solely on recurring business, and restated if the Group's structure should change significantly), must not exceed 2.85;
- the Interest Cover, calculated as the ratio of EBITDA (restated like the EBITDA used to calculate the leverage ratio) recorded in the last four quarters and the net interest owed in the same four quarters, must not exceed 4.9.
Typically, in the event of relevant acquisitions, the first two ratios may be increased to 2.20 and 3.26, respectively, for a period of not more than 12 months, twice over the life of the respective loans.

The trigger events for these covenants and the "spikes" relative to significant acquisitions (i.e. increase in benchmark index for maximum 12 months and twice along the duration of the financial liability) are summarized below:
| Primary Credit Facility Agreement | Leverage Ratio | Net Worth Ratio | Interest Cover (*) | Spike |
|---|---|---|---|---|
| - Medium/long-term bilateral loans with top-tier banking institutions of €219 million. |
≤ 2.85 | ≤ 1.65 | - | ≤ 3.26 (Leverage Ratio) |
| - Irrevocable credit lines with top-tier banking institutions of €125 million. |
≤ 2.20 (Net Worth Ratio) |
|||
| - €29 million bank loan expiring in 2025 - Revolving irrevocable credit line of €15 million |
≤ 2.85 | - | > 4.90 | ≤ 3.26 (Leverage Ratio) |
| -Medium/long-term bilateral loans with top-tier banking institutions of €66 million; -Irrevocable lines of credit with premier banks amounted to €115 million (of which €100 million is explained by the sustainability-linked facility). |
≤ 2.85 | ≤ 1.65 | > 4.90 | ≤ 3.26 (Leverage Ratio) ≤ 2.20 (Net Worth Ratio) |
The loan negotiated at the end of 2021, which replaced the €210 million syndicated loan used for the GAES acquisition, the new €300 million revolving facility negotiated at the end of May 2023 (both of which are sustainability-linked) and the €300 million loan, to date unutilized, granted by the European Investment Bank are not subject to covenants. However, the financial covenants on the other credit facilities will also be extended to these lenders as a result of a most favored clause.
The three financial covenants and the relative spikes, shown in the table above, are, therefore, applied to these credit lines to the extent that they are also applied to the other facilities.
As at 30 September 2023 these ratios were as follows:
| Value as at | |
|---|---|
| 09/30/2023 | |
| Net financial indebtedness excluding lease liabilities/Group net equity (Net Worth Ratio) | 0.86 |
| Net financial position excluding lease liabilities/EBITDA for the last four quarters (Leverage Ratio) | 1.63 |
| EBITDA for the last 4 quarters/Net financial expenses (Interest Cover) | 21.58 |

The above-mentioned ratios were determined based on an EBITDA which was restated and normalized, in order to reflect the main changes.
| (€ thousands) | Value as at 09/30/2023 |
|---|---|
| Group EBITDA first nine months 2023 | 372,585 |
| EBITDA October-December 2022 | 154,859 |
| Fair value of stock grant assignment | 24,575 |
| EBITDA normalized (from acquisitions and disposals) | 7,538 |
| Acquisitions and non-recurring costs | 3,672 |
| EBITDA for the covenant calculation | 563,229 |
The same agreements are also subject to other covenants applied in current international practice which limit the ability to issue guarantees and complete sales and lease backs, as well as extraordinary transactions involving the sale of assets.
10. Provision for risk and charges
Provisions for risks and charges amounted to €20,486 thousand, lower than the €21,607 thousand recorded at 31 December 2022.
The provisions for risks at 30 September 2023 are detailed below:
| (€ thousands) | 09/30/2023 | 12/31/2022 | Change |
|---|---|---|---|
| Product warranty provision | 1,178 | 1,261 | (83) |
| Provision on contract risks | 3,922 | 4,515 | (593) |
| Agents' leaving indemnities | 12,265 | 11,735 | 530 |
| Other reserves for risks and charges | 2,146 | 2,433 | (287) |
| Total Long-term provision for risk and charges | 19,511 | 19,944 | (433) |
| Product warranty provision | 223 | 323 | (100) |
| Other reserves for risks and charges | 752 | 1,340 | (588) |
| Total Short-term provision for risk and charges | 975 | 1,663 | (688) |
| Total provision for risk and charges | 20,486 | 21,607 | (1,121) |

11. Lease liabilities
The lease liabilities stem from long-term leases and rental agreements. These liabilities are equal to the present value of future installments payable over the lease term.
The finance lease liabilities are shown in the statement of financial position as follows:
| (€ thousands) | 09/30/2023 | 12/31/2022 | Change |
|---|---|---|---|
| Short term lease liabilities | 108,109 | 99,716 | 8,393 |
| Long term lease liabilities | 379,526 | 368,890 | 10,636 |
| Total lease liabilities | 487,635 | 468,606 | 19,029 |
The impact of the lease liabilities recognized in the reporting period on the income statement is shown below:
| First nine months | |
|---|---|
| (€ thousands) | 2023 |
| Interest charges on leased assets | (10,846) |
| Right-of-use depreciation | (87,908) |
| Costs for short-term leases and leases for low value assets | (11,211) |
12. Revenues from sales and services
| (€ thousands) | First nine months 2023 | First nine months 2022 | Change |
|---|---|---|---|
| Revenues from sale of products | 1,430,065 | 1,344,494 | 85,571 |
| Revenues from services | 215,000 | 195,201 | 19,799 |
| Total revenues from sales and services | 1,645,065 | 1,539,695 | 105,370 |
| Goods and services provided at a point in time | 1,430,065 | 1,344,494 | 85,571 |
| Goods and services provided over time | 215,000 | 195,201 | 19,799 |
| Total revenues from sales and services | 1,645,065 | 1,539,695 | 105,370 |
Consolidated revenues from sales and services amounted to €1,645,065 thousand in the first nine months of 2023, an increase of €105,370 thousand (+6.8%) compared to the same period of the prior year.
The increase compared to the first nine months of 2022 is attributable for €117,623 thousand to organic growth (+7.6%), acquisitions for €32,871 thousand (+2.1%) and negative exchange differences for €45,124 thousand (-2.9%).

13. Operating costs, depreciation and impairment, financial income-expenses and taxes
Operating costs amounted to €1,276,225 thousand in the first nine months of 2023 (€1,180,744 thousand in the first nine months of 2022), an increase of €95,481 thousand (+8.1%).
"Amortization, depreciation and impairment" amounted to €192,916 thousand at 30 September 2023 higher than the €178,278 thousand recorded in the first nine months of 2022.
"Financial income, expenses and value adjustments to financial assets" came to €36,893 thousand in the first nine months of 2023 (€25,572 thousand in the first nine months of 2022). The change in the reporting period of €11,321 thousand is explained by an increase in financial management costs attributable to: (i) the effect of the increase in interest rates on the use of short-term credit lines, of the variable-rate portion of medium- to long-term lines, of factoring, and of lease accounting; (ii) negative exchange rate differences related to the fluctuation of rates mainly in North and South American countries; and (iii) the greater negative impact of inflation accounting on the Argentine subsidiary.
Current and deferred tax amounted to €39,335 thousand in the first nine months of 2023, €4,954 thousand lower than in the first nine months of 2022 (€44,289 thousand). The tax rate was 27.6% in the reporting period versus 27.7% at 30 September 2022.

14. Performance Stock Grant
On May 2, 2023, the Board of Directors of Amplifon S.p.A., following the recommendation of the Remuneration and Nomination Committee, pursuant to Article 84 bis, paragraph 5 of Consob Regulation no. 11971/99 and subsequent amendments, resolved to allocate 517,500 target rights at the end of a 3-year vesting period as the first tranche of the Stock Grant Cycle 2023- 2025.
The fair value per unit of these granted stock grants during the reported period is €32.52.
Valuation Model Binomial Tree (Cox-Ross-Rubinstein method) Price at grant date €33.32 Threshold - € Exercise price 0.00 Volatility (3 years) 34.13% Risk-free interest rate 3.189% Maturiy (in years) 3 Maturity date 3 months after the approval date by the Board of Directors of the Consolidated Financial Statements as at December 31, 2025 (i.e., June 2026).
The assumptions used in determining the fair value are as follows:
The figurative cost of this grant cycle recorded in the income statement as of September 30, 2023 amounts to €1,883 thousand.
Expected Dividend Yield 0.79%
Sustainable value sharing plan 2022-2027
The Board of Directors of Amplifon S.p.A., following the recommendation of the Remuneration and Nomination Committee, pursuant to Article 84 bis, paragraph 5 of Consob Regulation no. 11971/99, has resolved to allocate a maximum of 122,620 rights under the Sustainable Value Sharing Plan 2022-2027, reserved for the CEO and Key Executives of the Group (Beneficiaries), as described in the Information Document approved by the Shareholders' Meeting on April 21, 2023.
The scheme is a composite incentive tool that operates through two distinct phases, of which the second phase is contingent and dependent on the progress of the first phase (referred to as "Phase A" and "Phase B," respectively). Phase A: Starting from the 2023 fiscal year, the Target MBO achieved and hypothetically due to the Beneficiaries under the applicable MBO Plan for the previous fiscal year (including the one related to 2022) will not be paid out. Instead, the Beneficiaries will receive a certain number of rights (the "Co-invested Rights") that will entitle them to receive shares at the end of the vesting period of Phase B described below, or earlier if Phase B does not vest.
Phase B: If, in a given fiscal year, the Beneficiaries receive Co-invested Rights under the mechanism described above, they will participate in an additional and separate incentive tool

based on financial instruments, wherein the Company allocates additional rights to them, equal in number to the Co-invested Rights. These rights (the "Matched Rights") will entitle the Beneficiaries to receive shares provided that certain performance targets linked to value generation and sustainable success of the Group are met by the end of the vesting period.
Regarding the Sustainable Value Sharing Plan 2022-2027 reserved for the CEO and Key Executives of the Group, the conversion of the accrued MBO led to the allocation of 61,310 Coinvested Rights and 61,310 Matched Rights.
| PHASE A | PHASE B | ||
|---|---|---|---|
| Valuation model | Binomial Tree (Cox-Ross-Rubinstein method) | Binomial Tree (Cox-Ross-Rubinstein method) | |
| FV | €32.10 | €26.03 | |
| KPI | - | ESG/TSR | |
| Exercise price | 0.00 | ||
| Volatility (3 years) | 33.84% | 33.84% | |
| Risk-free interest rate | 3.438% | 3.438% | |
| Maturity (in years) | 3 | 3 | |
| Maturity date | 3 months after the approval date by the Board of Directors of the Consolidated Financial Statements as at December 31, 2025. |
3 months after the approval date by the Board of Directors of the Consolidated Financial Statements as at December 31, 2025. |
|
| Expected dividend yield | 0.79% | 0.79% |
The assumptions used in determining the fair value are as follows:
On January 5, 2023, the controlling shareholder Ampliter S.r.l. ("Ampliter") established a plan that provides a one-time grant of 500,000 Amplifon shares owned by Ampliter to the CEO, Mr. Enrico Vita, during the term of office from 2022 to 2024. The shares are transferred free of charge in five tranches, with the first tranche consisting of 260,000 shares vesting on April 21, and the subsequent tranches of 60,000 shares each, with a final vesting date set for November 30, 2024.
This allocation, independently determined by Ampliter, although not involving any monetary outlay by Amplifon, requires the recognition of a one-time figurative cost in the income statement, in accordance with the IFRS 2 "Share Based Payments" accounting principle. The total figurative cost amounts to €13.7 million, of which €12.4 million will be recognized in the 2023 fiscal year and €1.3 million in the 2024 fiscal year.
The fair value per unit of these instruments, as per IFRS 13, is determined as the mark-to-market value (Level 1) of the rights at the date of allocation, which is EUR 27.43.
The figurative cost for the first half of the year, recorded as a non-recurring expense as of September 30, 2023, amounts to €11,614 thousand.

15. Non-recurring significant events
The first nine months of 2023 were impacted by the following non-recurring items:
| (€ thousands) | First nine months 2023 |
First nine months 2022 |
|
|---|---|---|---|
| Notional cost of the Amplifon shares assigned by the shareholder Ampliter to the CEO |
(11,614) | - | |
| Costs related to Bay Audio integration | (174) | (2,655) | |
| Costi operativi | Costs related to second phase of the GAES integration | (1,433) | (2,026) |
| Costs related to the charitable donation to the UNHCR for the Ukraine emergency. |
- | (1,000) | |
| EBITDA | (13,221) | (5,681) | |
| Profit (loss) before tax | (13,221) | (5,681) | |
| Impact of the above items on the tax burden for the period | 3,844 | 1,588 | |
| Total net profit (loss) | (9,377) | (4,093) |
16. Earnings (loss) per share
Basic Earnings (loss) per share
Basic earnings (loss) per share is obtained by dividing the net profit for the year attributable to the ordinary shareholders of the parent company by the weighted average number of shares outstanding in the period, considering purchases and disposals of own shares as cancellations and issues of shares.
Earnings per share are determined as follows:
| Earnings per share | First nine months 2023 | First nine months 2022 |
|---|---|---|
| Net profit (loss) attribuable to ordinary shareholders (€ thousand) | 103,438 | 115,484 |
| Average number of shares outstanding in the period | 224,054,021 | 224,293,768 |
| Average number per share (€ per share) | 0.46167 | 0.51488 |
Diluted earnings (loss) per share
Diluted earnings (loss) per share is obtained by dividing the net profit for the period attributable to the ordinary shareholders of the parent by the weighted average number of shares outstanding during the year adjusted by the diluting effects of potential shares. In the calculation of shares outstanding, purchases and sales of treasury shares are considered as cancellation or issue of shares.
The potential ordinary share categories refer to the possible conversion of Group employees' stock options and stock grants' attribution. The computation of the average number of

outstanding potential shares is based on the average fair value of shares for the period; stock options and stock grants are excluded from the calculation since they have anti-diluting effects.
| Weighted average diluted number of shares outstanding | First nine months 2023 | First nine months 2022 |
|---|---|---|
| Average number of shares outstanding in the period | 224,054,021 | 224,293,768 |
| Weighted average of potential and diluting ordinary shares | 1,766,662 | 2,563,049 |
| Weighted average of shares potentially subject to options in the period | 225,820,683 | 226,856,817 |
The diluted earnings per share were determined as follows:
| Diluted earnings per share | First nine months 2023 | First nine months 2022 |
|---|---|---|
| Net profit attributable to ordinary shareholders (€ thousand) | 103,438 | 115,484 |
| Average number of shares outstanding in the period | 225,820,683 | 226,856,817 |
| Average diluted earnings per share (€) | 0.45805 | 0.50906 |

17. Transactions with parents and other related parties
The parent company, Amplifon S.p.A. is based in Via Ripamonti 133, Milan, Italy. The Group is controlled directly by Ampliter S.r.l. (42.12% of share capital and 59.16% of voting rights), held for a 100.0% by Amplifin S.p.A., which is 99.4% owned by Susan Carol Holland and the remaining 0.6% in treasury shares.
The transactions with related parties, including intercompany transactions, do not qualify as atypical or unusual, and fall within the Group's normal course of business and are conducted at arm's-length as dictated by the nature of the goods and services provided.
| 09/30/2023 | First nine months 2023 | |||||
|---|---|---|---|---|---|---|
| (€ thousand) | Trade receivables | Trade payables | Revenues for sales and services |
Operating (costs)/revenues |
Interest income and expense |
|
| Amplifin S.p.A. | 10 | - | - | (60) | 3 | |
| Total – Parent company | 10 | - | - | (60) | 3 | |
| Comfoor BV (The Netherlands) | 21 | 2,774 | 74 | (876) | - | |
| Ruti Levinson Institute Ltd (Israel) | 45 | - | - | - | - | |
| Afik - Test Diagnosis & Hearing Aids Ltd (Israel) |
84 | - | - | - | - | |
| Total – Other related parties | 150 | 2,774 | 74 | (876) | - | |
| Total related parties | 160 | 2,774 | 74 | (936) | 3 | |
| Total as per financial statements | 202,889 | 324,454 | 1,645,065 | (1,276,225) | (19,036) | |
| % of financial statements total | 0.08% | 0.85% | 0.00% | 0.07% | -0.02% |
The following table details transactions with related parties:
The trade and other receivables refer primarily to:
- the recovery of maintenance costs and building fees from Amplifin S.p.A.;
- the receivables due by Amplifin S.p.A. for the renovation of the headquarters based on modern and efficient standards for the use of workspaces;
- the trade receivables due by associates (mainly in Israel) who act as resellers and to which the Group supplies hearing aids.
The trade payables and operating costs refer primarily to commercial transactions with Comfoor BV, a joint venture from which hearing protection devices are purchased and then distributed in Group stores.
The lease for the Milan headquarters (leased to Amplifon by the parent company Amplifin) is recognized under right-of-use depreciation for €1,362 thousand, interest on leases for €332 thousand, lease liabilities of €12,408 thousand, and right-of-use asset of €11,338 thousand.

The assignment of Amplifon shares by Ampliter S.r.l. to the CEO Enrico Vita described in note 14, is a transaction between related parties and not a transaction with related parties.
18. Contingent liabilities
Currently the Group is not exposed to any particular risks, uncertainties or legal disputes in excess of the provisions already made in the financial statements, shown in Note 10. The usual tax audits are currently underway and no findings of note have been reported so far and the Group is, at any rate, confident in the adequacy of the measures implemented.
19. Financial risk management
As this condensed consolidated interim financial report does not include all the additional information that is mandatorily included in the Annual Report relating to the management of financial risk, for a detailed analysis of financial risk management reference should be made to the Group's 2022 Annual Report.

20. Translation of foreign companies' financial statements
The exchange rates used to translate non-Euro zone companies' financial statements are as follows:
| 30 September 2023 | 2022 | 30 September 2022 | ||||
|---|---|---|---|---|---|---|
| Average exchange rate |
As at 30 September |
As at 31 December |
Average exchange rate |
As at 30 September |
||
| Panamanian balboa | 1.0833 | 1.0594 | 1.0660 | 1.0638 | 0.9748 | |
| Australian dollar | 1.6205 | 1.6339 | 1.5693 | 1.5044 | 1.5076 | |
| Canadian dollar | 1.4576 | 1.4227 | 1.4440 | 1.3643 | 1.3401 | |
| New Zealand dollar | 1.7547 | 1.7575 | 1.6798 | 1.6468 | 1.7177 | |
| Singapore dollar | 1.4523 | 1.4443 | 1.4300 | 1.4631 | 1.4001 | |
| US dollar | 1.0833 | 1.0594 | 1.0666 | 1.0638 | 0.9748 | |
| Hungarian florin | 381.7600 | 389.5000 | 400.87 | 384.81 | 422.18 | |
| Swiss franc | 0.9774 | 0.9669 | 0.9847 | 1.0118 | 0.9561 | |
| Egyptian lira | 33.1383 | 32.7298 | 26.3990 | 19.011 | 19.053 | |
| New Israeli shekel | 3.9474 | 4.0472 | 3.7554 | 3.5254 | 3.4759 | |
| Argentine peso (*) | 370.8149 | 370.8149 | 188.5033 | 143.3764 | 143.3764 | |
| Chilean peso | 890.0800 | 959.8000 | 913.82 | 912.74 | 939.73 | |
| Colombian peso | 4772.1400 | 4312.3900 | 5172.47 | 4.326.45 | 4.415.55 | |
| Mexican peso | 19.2804 | 18.5030 | 20.8560 | 21.5542 | 19.6393 | |
| Brazilian real | 5.4245 | 5.3065 | 5.6386 | 5.4631 | 5.2584 | |
| Chinese renminbi | 7.6235 | 7.7352 | 7.3582 | 7.0193 | 6.9368 | |
| Indian rupee | 89.2314 | 88.0165 | 88.1710 | 82.2983 | 79.4250 | |
| British pound | 0.8707 | 0.8646 | 0.8869 | 0.8472 | 0.8830 | |
| Polish zloty | 4.5820 | 4.6283 | 4.6808 | 4.6724 | 4.8483 |
(*) Argentina is a highly inflationary country. As requested by IAS 29, profit and loss items have been converted at the closing exchange rate.
The average Argentine peso exchange rate as at 30 September 2023 is 253.2357 and as at 30 September 2022 is 127.2470.

21. Segment reporting
In accordance with IFRS 8 "Operating Segments", the schedules related to each operating segment are shown below.
The Amplifon Group's business (distribution and customization of hearing solutions) is organized into three specific geographical areas which comprise the Group's operating segments: Europe, Middle-East and Africa - EMEA - (Italy, France, The Netherlands, Germany, the United Kingdom, Spain, Portugal, Switzerland, Belgium, Hungary, Egypt, Poland, and Israel), Americas (USA, Canada, Chile, Argentina, Ecuador, Colombia, Panama, and Mexico) and Asia-Pacific (Australia, New Zealand, India, and China).
The Group also operates via centralized Corporate functions (Corporate bodies, general management, business development, procurement, treasury, legal affairs, human resources, IT systems, global marketing and internal audit) which do not qualify as operating segments under IFRS 8.
These areas of responsibility, which coincide with the geographical areas (the Corporate functions are recognized under EMEA), represent the organizational structure used by management to run the Group's operations. The reports periodically analyzed by the Chief Executive Officer and Top Management are divided up accordingly, by geographical area.
Performances are monitored and measured for each operating segment/geographical area, through operating profit including amortization and depreciation (EBIT), along with the portion of the results of equity investments in associated companies valued by using the equity method. Financial expenses are not monitored insofar as they are based on corporate decisions regarding the financing of each region (own funds versus borrowings) and, consequently, neither are taxes. Items in the statement of financial position are analyzed by the geographical area without being separated from the Corporate functions which remain part of EMEA. All the information relating to the income statement and the statement of financial position is determined using the same criteria and accounting standards used to prepare the consolidated financial statements.

| (€ thousands) | EMEA | AMERICAS | APAC | ELIM. | CONSOLIDATED |
|---|---|---|---|---|---|
| ASSETS | |||||
| Non-current assets | |||||
| Goodwill | 945,325 | 247,211 | 601,787 | - | 1,794,323 |
| Intangible fixed assets with finite useful life | 305,275 | 56,454 | 63,435 | - | 425,164 |
| Property, plant, and equipment | 144,014 | 26,588 | 37,095 | - | 207,697 |
| Right-of-use assets | 367,257 | 45,463 | 55,506 | - | 468,226 |
| Equity-accounted investments | 2,293 | - | - | - | 2,293 |
| Hedging instruments | 19,429 | - | - | - | 19,429 |
| Deferred tax assets | 65,713 | 11,527 | 10,953 | - | 88,193 |
| Deferred contract costs | 11,395 | 1,145 | 43 | - | 12,583 |
| Other assets | 31,423 | 13,332 | 1,822 | - | 46,577 |
| Total non-current assets | 3,064,485 | ||||
| Current assets | |||||
| Inventories | 68,809 | 6,384 | 9,519 | - | 84,712 |
| Receivables | 290,505 | 47,089 | 29,708 | (61,113) | 306,189 |
| Deferred contract costs | 3,723 | 1,040 | 137 | - | 4,900 |
| Hedging instruments | 218 | - | - | - | 218 |
| Other financial assets | 51,021 | ||||
| Cash and cash equivalents | 146,767 | ||||
| Total current assets | 593,807 | ||||
| TOTAL ASSETS | 3,658,292 | ||||
| LIABILITIES | |||||
| Net Equity | 1,070,715 | ||||
| Non-current liabilities | |||||
| Medium/long-term financial liabilities | 656,904 | ||||
| Lease liabilities | 303,036 | 37,849 | 38,641 | - | 379,526 |
| Provisions for risks and charges | 17,298 | 841 | 1,372 | - | 19,511 |
| Liabilities for employees' benefits | 9,141 | 200 | 758 | - | 10,099 |
| Hedging instruments | - | - | - | - | - |
| Deferred tax liabilities | 62,396 | 26,176 | 17,325 | - | 105,897 |
| Payables for business acquisitions | 5,363 | 1,454 | - | - | 6,817 |
| Contract liabilities | 143,679 | 13,306 | 2,401 | - | 159,386 |
| Other long-term liabilities | 20,257 | 1,171 | - | - | 21,428 |
| Total non-current liabilities | 1,359,568 | ||||
| Current assets | |||||
| Trade payables | 269,587 | 68,429 | 47,356 | (60,918) | 324,454 |
| Payables for business acquisitions | 3,379 | 5,686 | 292 | - | 9,357 |
| Contract liabilities | 89,134 | 15,815 | 7,688 | - | 112,637 |
| Other payables and tax payables | 183,795 | 22,977 | 23,528 | (195) | 230,105 |
| Hedging instruments | 384 | - | - | - | 384 |
| Provisions for risks and charges | 265 | 710 | - | - | 975 |
| Liabilities for employees' benefits | 790 | 329 | 2,249 | - | 3,368 |
| Short-term financial liabilities | 438,620 | ||||
| Lease liabilities | 77,156 | 10,977 | 19,976 | - | 108,109 |
| Total current liabilities | 1,228,009 | ||||
| TOTAL LIABILITIES | 3,658,292 |
Statement of Financial Position as at September 30th , 2023 (*)
(*) The items in the statement of financial position are analyzed by the CEO and Top Management by geographic area without being separated from the Corporate functions which are included in EMEA.

Statement of Financial Position as at December 31st, 2022 (*)
| (€ thousands) | EMEA | AMERICAS | APAC | ELIM. | CONSOLIDATED |
|---|---|---|---|---|---|
| ASSETS | |||||
| Non-current assets | |||||
| Goodwill | 921,163 | 213,816 | 619,049 | - | 1,754,028 |
| Intangible fixed assets with finite useful life | 298,642 | 53,903 | 67,553 | - | 420,098 |
| Property, plant, and equipment | 136,721 | 21,006 | 35,688 | - | 193,415 |
| Right-of-use assets | 366,243 | 34,242 | 51,262 | - | 451,747 |
| Equity-accounted investments | 2,093 | - | - | - | 2,093 |
| Hedging instruments | 25,850 | - | - | - | 25,850 |
| Deferred tax assets | 60,867 | 10,206 | 10,707 | - | 81,780 |
| Deferred contract costs | 9,841 | 1,206 | 84 | - | 11,131 |
| Other assets | 30,361 | 10,494 | 1,615 | - | 42,470 |
| Total non-current assets | 2,982,612 | ||||
| Current assets | |||||
| Inventories | 60,417 | 5,781 | 10,060 | - | 76,258 |
| Receivables | 270,798 | 54,107 | 33,985 | (94,213) | 264,677 |
| Deferred contract costs | 4,437 | 744 | 81 | - | 5,262 |
| Hedging instruments | 17,016 | - | - | - | 17,016 |
| Other financial assets | 49,986 | ||||
| Cash and cash equivalents | 179,654 | ||||
| Total current assets | 592,853 | ||||
| TOTAL ASSETS | 3,575,465 | ||||
| LIABILITIES | |||||
| Net Equity | 1,040,350 | ||||
| Non-current liabilities | |||||
| Medium/long-term financial liabilities | 798,940 | ||||
| Lease liabilities | 304,182 | 28,995 | 35,713 | - | 368,890 |
| Provisions for risks and charges | 17,712 | 787 | 1,445 | - | 19,944 |
| Liabilities for employees' benefits | 8,023 | 203 | 714 | - | 8,940 |
| Hedging instruments | - | - | - | - | - |
| Deferred tax liabilities | 61,419 | 26,053 | 19,211 | - | 106,683 |
| Payables for business acquisitions | 3,209 | 2,496 | - | - | 5,705 |
| Contract liabilities | 136,574 | 14,744 | 2,295 | - | 153,613 |
| Other long-term liabilities | 15,149 | 974 | - | - | 16,123 |
| Total non-current liabilities | 1,478,838 | ||||
| Current assets | |||||
| Trade payables | 310,412 | 68,611 | 40,574 | (94,014) | 325,583 |
| Payables for business acquisitions | 7,585 | 17,016 | - | - | 24,601 |
| Contract liabilities | 91,613 | 15,034 | 8,210 | - | 114,857 |
| Other payables and tax payables | 192,769 | 19,919 | 30,092 | (199) | 242,581 |
| Hedging instruments | - | - | - | - | - |
| Provisions for risks and charges | 975 | 688 | - | - | 1,663 |
| Liabilities for employees' benefits | 789 | 393 | 2,434 | - | 3,616 |
| Short-term financial liabilities | 243,661 | ||||
| Lease liabilities | 73,798 | 7,827 | 18,090 | - | 99,716 |
| Total current liabilities | 1,056,277 | ||||
| TOTAL LIABILITIES | 3,575,465 |
(*) The items in the statement of financial position are analyzed by the CEO and Top Management by geographic area without being separated from the Corporate functions which are included in EMEA.

Income Statement – First nine months 2023 (*)
| (€ thousands) | EMEA | AMERICAS | ASIA PACIFIC |
CORPORATE | ELIM. | CONSOLIDATED |
|---|---|---|---|---|---|---|
| Revenues from sales and services | 1,067,232 | 321,984 | 255,511 | 338 | - | 1,645,065 |
| Operating costs | (771,871) | (237,908) | (189,209) | (77,237) | - | (1,276,225) |
| Other income and costs | 3,473 | (127) | (10) | 409 | - | 3,745 |
| Gross operating profit by segment | ||||||
| (EBITDA) | 298,834 | 83,949 | 66,292 | (76,490) | - | 372,585 |
| Amortization, depreciation and impairment |
||||||
| Intangible assets amortization | (30,732) | (7,322) | (10,948) | (16,317) | - | (65,319) |
| Property, plant, and equipment depreciation |
(24,581) | (4,727) | (8,110) | (2,068) | - | (39,486) |
| Right-of-use depreciation | (58,042) | (8,675) | (19,491) | (1,700) | - | (87,908) |
| Impairment losses and reversals of non current assets |
(189) | (5) | (9) | - | - | (203) |
| (113,544) | (20,729) | (38,558) | (20,085) | - | (192,916) | |
| Operating result by segment | 185,290 | 63,220 | 27,734 | (96,575) | - | 179,669 |
| Financial income, expenses and value adjustments to financial assets |
||||||
| Group's share of the result of associated companies valued at equity and gains/losses on disposals of equity investments |
210 | - | - | - | - | 210 |
| Interest income and expenses | (19,036) | |||||
| Interest expenses on lease liabilities | (10,846) | |||||
| Other financial income and expenses | (3,528) | |||||
| Exchange gains and losses, and inflation accounting |
(4,438) | |||||
| Gain (loss) on assets accounted at fair value |
745 | |||||
| (36,893) | ||||||
| Net profit (loss) before tax | 142,776 | |||||
| Current and deferred income tax | ||||||
| Current income tax | (46,218) | |||||
| Deferred tax | 6,883 | |||||
| (39,335) | ||||||
| Net profit (loss) | 103,441 | |||||
| Net profit (loss) attributable to Minority interests |
3 | |||||
| Net profit (loss) attributable to the Group | 103,438 |
(*) The figures of the operating segments are net of the intercompany eliminations.

| (€ thousands) | EMEA | AMERICAS | APAC | CORPORATE | ELIM. | CONSOLIDATED |
|---|---|---|---|---|---|---|
| Revenues from sales and services | 1,019,254 | 282,043 | 237,986 | 412 | - | 1,539,695 |
| Operating costs | (734,181) | (207,547) | (178,175) | (60,841) | - | (1,180,744) |
| Other income and costs | 4,774 | (1,040) | 205 | 959 | - | 4,898 |
| Gross operating profit by segment (EBITDA) |
289,847 | 73,456 | 60,016 | (59,470) | - | 363,849 |
| Amortization, depreciation and impairment |
||||||
| Intangible assets amortization | (27,442) | (7,767) | (11,925) | (11,988) | - | (59,122) |
| Property, plant, and equipment depreciation |
(25,613) | (3,336) | (6,879) | (2,066) | - | (37,894) |
| Right-of-use depreciation | (56,187) | (5,791) | (17,378) | (1,701) | - | (81,057) |
| Impairment losses and reversals of non current assets |
(248) | 64 | (21) | - | - | (205) |
| (109,490) | (16,830) | (36,203) | (15,755) | - | (178,278) | |
| Operating result by segment | 180,357 | 56,626 | 23,813 | (75,225) | - | 185,571 |
| Financial income, expenses and value adjustments to financial assets Group's share of the result of associated companies valued at equity and gains/losses on disposals of equity |
323 | - | - | - | - | 323 |
| investments Interest income and expenses |
(13,923) | |||||
| Interest expenses on lease liabilities | (8,332) | |||||
| Other financial income and expenses | (1,728) | |||||
| Exchange gains and losses, and inflation accounting |
651 | |||||
| Gain (loss) on assets accounted at fair value |
(2,563) | |||||
| (25,572) | ||||||
| Net profit (loss) before tax | 159,999 | |||||
| Current and deferred income tax | ||||||
| Current income tax | (57,591) | |||||
| Deferred tax | 13,302 | |||||
| (44,289) | ||||||
| Net profit (loss) | 115,710 | |||||
| Net profit (loss) attributable to Minority interests |
226 | |||||
| Net profit (loss) attributable to the Group | 115,484 |
Income Statement – First nine months 2022 (*)
(*) The figures of the operating segments are net of the intercompany eliminations.

22. Accounting policies
22.1 Presentation of financial statements
The Interim Financial Report as at 30 September 2023 was prepared in accordance with the historical cost method with the exception of derivatives, a few financial investments measured at fair value and assets and liabilities hedged against changes in fair value, as explained in more detail in this report, as well as on a going concern basis.
With regard to the financial statements, the following is specified:
- in the statement of financial position, the Group distinguishes between non-current and current assets and liabilities;
- in the income statement, the Group classifies costs by nature insofar as this is deemed to provide a more accurate representation of the Group's primarily commercial and distribution activities;
- comprehensive income statement: in addition to the net result for the year, it includes the impact of differences in exchange rates, the cash flow hedge reserve, the foreign currency basis spread reserve for derivatives, as well as the actuarial gains and losses that have been recognized directly in changes in shareholders' equity, these items are divided according to whether or not they can be subsequently reclassified to the income statement
- statement of changes in net equity: the Group reports all the changes in net equity, including those deriving from shareholder transactions (payment of dividends and capital increases);
- statement of cash flows: is prepared using the indirect method to determine cash flow from operations.
22.2 Use of estimates in preparing the financial statements
The preparation of the financial statements and explanatory notes requires the use of estimates and assumptions particularly with regard to the following items:
- revenues for services rendered over time recognized based on the input or output needed to satisfy the performance obligation;
- allowances for impairment made based on the asset's estimated realizable value;
- provisions for risks and charges made based on a reasonable estimate of the amount of the potential liability, including with regard to any counterparty claims;
- provisions for obsolete inventories in order to align the carrying value of inventories with the estimated realizable value;
- provisions for employee benefits, calculated based on actuarial valuations;
- amortization and depreciation of intangible assets, tangible fixed assets and right of use assets recognized based on the estimated remaining useful life and the recoverable amount; - income tax recognized based on the best estimate of the tax rate for the full year;
- IRSs and currency swaps (instruments not traded on regulated markets), marked to market at the reporting date based on the yield curve and market exchange rates, which are subject to credit/debit valuation adjustments based on market prices;

- the lease term duration was determined on a lease-by-lease basis and is comprised of the "non-cancellable" period along with the impact of any extension or early termination clauses if exercise of that clause is reasonably certain and taking into account any and all lease clauses;
- discount rate of leases falling within the scope of IFRS 16 (incremental borrowing rate) determined based on the IRS (reference interbank rate used as an index for fixed-rate mortgage loans) in the individual countries in which Amplifon Group companies operate, for maturities commensurate with the duration of the specific rental agreement, plus the Parent Company's credit spread and any costs for additional guarantees. In the rare instances when the IRS rate is not available (Egypt, Ecuador, Mexico and Panama), the risk-free rate was determined based on government bonds with maturities similar to the duration of the specific rental agreement.
Estimates are periodically reviewed, and any changes made, following the change of the circumstances based on which the estimates were made or the availability of better information, are recognized in the income statement. The use of reasonable estimates is essential to the preparation of the financial statements and does not affect their overall reliability.
The Group verifies the existence of a loss in value of goodwill regularly, once a year or in the event of impairment indicators. This calls for an estimate of the value in use of the cash generating units to which the goodwill refers based on an estimate of future cash flows and the after-tax discount rate which reflects market conditions at the valuation date.

22.3 IFRS standards/interpretations approved by the IASB and endorsed in Europe
The following table lists the IFRS/interpretations approved by the IASB, endorsed in Europe and applied for the first time this year.
| Description | Endorsement date |
Publication in the G.U.C.E. |
Effective date | Effective date for Amplifon |
|---|---|---|---|---|
| Amendment to IAS 1 "Presentation of Financial Statements" e IFRS Practice Statement 2: Disclosure of Accounting Policies (issued on 12 February 2021) |
2 Mar '22 | 3 Mar '22 | 1 Jan '23 | 1 Jan '23 |
| IFRS 17 "Insurance Contracts" (issued on 18 May 2017); including amendments to IFRS 17 (issued on 25 June 2020) |
19 Nov '21 | 23 Nov '21 | 1 Jan '23 | 1 Jan '23 |
| Amendment to IFRS 17 "Insurance contracts" and IFRS 9 (issued on 9 December 2021) |
8 Sep '22 | 9 Set '22 | 1 Jan '23 | 1 Jan '23 |
| Amendment to IAS 12 "Income Taxes: Deferred Tax related to Assets and Liabilities arising from a Single Transaction (issued on 7 May 2021) |
11 Aug '22 | 12 Aug '22 | 1 Jan '23 | 1 Jan '23 |
| Amendment to IAS 8 "Accounting policies, Changes in Accounting Estimates and Errors: Definition of Accounting Estimates" (issued on 12 February 2021) |
2 Mar '22 | 3 Mar '22 | 1 Jan '23 | 1 Jan '23 |
Amendments to IAS 1 "Presentation of Financial Statements" and "IFRS Practice Statement 2 Disclosure of Accounting Policies" which strive to improve accounting policy disclosures, in order to provide investors and other primary users of the financial statements with more useful information, as well as help companies clarify the distinction between changes in accounting policies and changes in accounting estimates.
IFRS 17 "Insurance Contracts" is a new standard which relates to the recognition and measurement, presentation and disclosure of insurance contracts which will substitute IFRS 4, issued in 2005. This standard is applicable to all types of insurance contracts, regardless of the issuer, as well as to a few guarantees and financial instruments with discretionary participation features.
Amendments to IAS 12 "Income Taxes: Deferred Tax related to Assets and Liabilities arising from a Single Transaction" calls for exceptions to the "initial recognition exemption" provided in IAS 12.25 (b) and IAS 12.24. The provision impacts the calculation of the tax liability recorded upon "initial recognition".

Amendments to IAS 8 ''Accounting policies, Changes in Accounting Estimates and Errors'' which allow the entities to distinguish between accounting principle and accounting estimates through the introduction of a new definition of ''accounting estimates''.
The adoption of the above standards and interpretations is not expected to have a material impact on the measurement of the Group's assets, liabilities, costs and revenues.
22.4 Future accounting standards and interpretations
IFRS standards/interpretations approved by IASB, but not endorsed in Europe
The following are the international accounting standards, interpretations, amendments to existing accounting standards and interpretations, or specific provisions contained in the standards and interpretations approved by the IASB which, at 30 October 2023, had yet to be endorsed for adoption in Europe.
| Description | Effective date |
|---|---|
| Amendments to IAS 12 "Income taxes: International Tax Reform – Pillar Two Model Rules" (issued on 23 May 2023) |
Periods beginning on or after 1 Jan '23 |
| Amendments to IAS 1: "Presentation of Financial Statements: Classification of liabilities as current or non-current", "Classification of Liabilities as Current or Non-current - Deferral of Effective Date" and ''Non-current Liabilities with Covenants'' |
Periods beginning on or after 1 Jan '24 |
| (issued on 23 January 2020, 15 July 2020 and 31 October 2022, respectively) | |
| Amendments to IFRS 16 "Leases: Lease Liability in a Sale and Leaseback" (issued on 22 September 2022) |
Periods beginning on or after 1 Jan '24 |
| Amendments to IAS 7 ''Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures: Supplier Finance Arrangements'' (issued on 25 May 2023) |
Periods beginning on or after 1 Jan '24 |
| Amendments to IAS 21 "The Effects of Changes in Foreign Exchange Rates: Lack of Exchangeability" (issued on 15 August 2023) |
Periods beginning on or after 1 Jan '25 |
The IAS 12 amendments provide temporary mandatory relief from deferred tax accounting for minimum top-up tax. While waiting for these amendments to be endorsed in Italy and the Group's other countries of operation, the analysis of any potential impact, which is expected to be immaterial, is being carried out.
IAS 1 amendments are related to the definitions of current and non-current liabilities, providing a more generalized approach to the classification of liabilities under the standard, based on the contractual agreements.
IFRS 16 amendments are related to the definitions of liabilities derived from leasebacks and the accounting treatment of any gains or losses stemming from these transactions.
IAS 7 amendments refer to the disclosure of information deemed relevant for the purposes of Supplier Finance Arrangements.
The amendments to IAS 21 proposed by IASB provide clarification as to exchange whether a currency is exchangeable and which exchange rate to be use if it is not.

The adoption of the standards and interpretations above is not expected to have a material impact on the measurement of the Group's assets, liabilities, costs and revenues.

23. Subsequent events
After 30 September 2023, the exercise of the performance stock grants continued, and the beneficiaries received a total of 6,650 treasury shares. At the date of this report, the Company had a total of 871,483 treasury shares or 0.385% of its share capital.
The Group's external growth also continued in October 2023 with the acquisition of a total of 49 shops in China, the US, France, and Germany.
Milan, October 30th , 2023
CEO
Enrico Vita

Annexes
Annex I
Consolidation scope
As required by articles 38 and 39 of Law 127/91 and article 126 of Consob's resolution 11971 dated 14 May 1999, as amended by resolution 12475 dated 6 April 2000, the following is the list of companies included in the consolidation scope of Amplifon S.p.A. at 30 September 2023.
Parent company:
| Company name | Head office | Currency | Share capital |
|---|---|---|---|
| Amplifon S.p.A. | Milano (Italy) | EUR | 4,527,772 |
Subsidiaries consolidated using the line-by-line method:
| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 09/30/2023 |
|---|---|---|---|---|---|
| Amplifon Italia S.p.A | Milano (Italy) | D | EUR | 100,000 | 100.0% |
| Amplifon Rete | Milano (Italy) | I | EUR | 19,250 | 2.6% |
| Audibel S.r.l (in liquidazione) | Roma (Italy) | D | EUR | 70,000 | 100.0% |
| Pilot Blankenfelde Medizinisch Elektronische Gerate GmbH |
Blankenfelde-Mahlow (Germany) |
D | EUR | 34,595 | 100.0% |
| Amplifon France SAS | Arcueil (France) | D | EUR | 173,550,898 | 100.0% |
| SCI Eliot Leslie | Lyon (France) | I | EUR | 610 | 100.0% |
| Audition Frederic Rembaud | Périgueux (France) | I | EUR | 40,000 | 100.0% |
| Audition 50 | Granville (France) | I | EUR | 40,000 | 100.0% |
| Audition Marquilly | Lavelanet (France) | I | EUR | 15,000 | 100.0% |
| Surdité Toulorge | Cherbourg (France) | I | EUR | 3,920 | 100.0% |
| NewEar | Guidel (France) | I | EUR | 502,830 | 100.0% |
| Ghama | Guidel (France) | I | EUR | 5,000 | 100.0% |
| Adagio | Guidel (France) | I | EUR | 14,000 | 100.0% |
| Audition Guidel | Guidel (France) | I | EUR | 1,500 | 100.0% |
| Octave Audition | Moret Loing et Orvanne (France) |
I | EUR | 10,000 | 100.0% |
| Argenteuil Acoustique Médicale | Argenteuil (France) | I | EUR | 13,000 | 100.0% |
| SAS Galy | Fronton (France) | I | EUR | 5,000 | 100.0% |
| Labo Audio | Libourne (France) | I | EUR | 50,000 | 100.0% |
| N.C. Audition | Saint-Genis-Laval (France) |
I | EUR | 1,000 | 100.0% |
| Toumelin | Pornichet (France) | I | EUR | 7,622 | 100.0% |
| Pornic Audition | Pornic (France) | I | EUR | 118,000 | 100.0% |
| Audio Montfermeil | Montfermeil (France) | I | EUR | 1,000 | 100.0% |
| LCA Rodez | Rodez (France) | I | EUR | 5,000 | 100.0% |
| Amplitude Audition | Prades-le-Lez (France) | I | EUR | 1,000 | 100.0% |
| Boulben Audition - Majuni | Queven (France) | I | EUR | 15,000 | 100.0% |

| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 09/30/2023 |
|---|---|---|---|---|---|
| Audition du Segala | Baraqueville (France) | I | EUR | 1,500 | 100.0% |
| Amplifon Iberica SA | Barcelona (Spain) | D | EUR | 26,578,809 | 100.0% |
| Microson S.A. | Barcelona (Spain) | D | EUR | 61,752 | 100.0% |
| Amplifon LATAM Holding S.L. | Barcelona (Spain) | I | EUR | 3,000 | 100.0% |
| Amplifon Portugal SA | Lisboa (Portugal) | I | EUR | 15,520,187 | 100.0% |
| Amplifon Magyarország Kft | Budapest (Hungary) | D | HUF | 723,500,000 | 100.0% |
| Amplibus Magyarország Kft | Budaörs (Hungary) | I | HUF | 3,000,000 | 100.0% |
| Amplifon AG | Baar (Switzerland) | D | CHF | 1,000,000 | 100.0% |
| Amplifon Nederland BV | Doesburg (The Netherlands) |
D | EUR | 74,212,052 | 100.0% |
| Auditech BV | Doesburg (The Netherlands) |
I | EUR | 22,500 | 100.0% |
| Electro Medical Instruments BV | Doesburg (The Netherlands) |
I | EUR | 16,650 | 100.0% |
| Beter Horen BV | Doesburg (The Netherlands) |
I | EUR | 18,000 | 100.0% |
| Amplifon Customer Care Service BV | Elst (The Netherlands) | I | EUR | 18,000 | 100.0% |
| Amplifon Belgium NV | Bruxelles (Belgium) | D | EUR | 495,800 | 100.0% |
| Amplifon RE SA | Luxembourg (Luxembourg) |
D | EUR | 3,700,000 | 100.0% |
| Amplifon Deutschland GmbH | Hamburg (Germany) | D | EUR | 6,026,000 | 100.0% |
| Focus Hören AG | Willroth (Germany) | I | EUR | 485,555 | 100.0% |
| Focus Hören Deutschland GmbH | Willroth (Germany) | I | EUR | 25,000 | 100.0% |
| Amplifon Poland Sp. z o.o. | Lodz (Poland) | D | PLN | 3,348,280 | 100.0% |
| Amplifon UK Ltd | Manchester (United Kingdom) |
D | GBP | 130,951,168 | 100.0% |
| Amplifon Ltd | Manchester (United Kingdom) |
I | GBP | 1,800,000 | 100.0% |
| Ultra Finance Ltd | Manchester (United Kingdom) |
I | GBP | 75 | 100.0% |
| Amplifon Cell | Ta' Xbiex (Malta) | D | EUR | 2,500,125 | 100.0% |
| Medtechnica Ortophone Ltd (*) | Tel Aviv (Israel) | D | ILS | 1,100 | 90.0% |
| Amplifon Middle East SAE | Cairo (Egypt) | D | EGP | 3,000,000 | 51.0% |
| Miracle Ear Inc. | St. Paul (United States) | I | USD | 5 | 100.0% |
| Elite Hearing, LLC | Minneapolis (United States) |
I | USD | 1,000 | 100.0% |
| Amplifon USA Inc. | Dover (United States) | D | USD | 52,500,010 | 100.0% |
| Amplifon Hearing Health Care. Inc. | St. Paul (United States) | I | USD | 10 | 100.0% |
| Ampifon IPA, LLC | New York (United States) |
I | USD | 1,000 | 100.0% |
| ME Pivot Holdings, LLC | Minneapolis (United States) |
I | USD | 2,000,000 | 100.0% |
| ME Flagship, LLC | Wilmington (United States) |
I | USD | - | 100.0% |
| METX, LLC | Waco (United States) | I | USD | - | 100.0% |
| MEFL, LLC | Waco (United States) | I | USD | - | 100.0% |
| METAMPA, LLC | Waco (United States) | I | USD | - | 100.0% |
| MENM, LLC | Waco (United States) | I | USD | - | 100.0% |
| MEOH, LLC | Minneapolis (United States) |
I | USD | - | 100.0% |
| Miracle Ear Canada Ltd. | Vancouver (Canada) | I | CAD | 125,901,200 | 100.0% |

| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 09/30/2023 |
|---|---|---|---|---|---|
| 2829663 Ontario Inc | Milton (Canada) | I | CAD | - | 100.0% |
| Ossicle Fort McMurray Inc | Fort McMurray (Canada) |
I | CAD | - | 100.0% |
| Southern Alberta Hearing Aid Ltd | Lethbridge (Canada) | I | CAD | - | 100.0% |
| Burnaby Hearing Center Inc | Burnaby (Canada) | I | CAD | - | 100.0% |
| Raindrop Hearing Clinici Inc | Toronto (Canada) | I | CAD | - | 100.0% |
| Terrace Hearing Clinic Ltd. | Terrace (Canada) | I | CAD | - | 100.0% |
| The Hearing Clinic | Scarborough (Canada) | I | CAD | - | 100.0% |
| Lisa Reid Audiology Hearing Centres | Manitoba (Canada) | I | CAD | - | 100.0% |
| Great to Hear, Inc | Manitoba (Canada) | I | CAD | 35 | 100.0% |
| Ontario, Inc | Ontario (Canada) | I | CAD | 1,000,100 | 100.0% |
| Living Sounds Hearing Centre Ltd. | Alberta (Canada) | I | CAD | 100 | 100.0% |
| Professional Hearing Services Ltd./100391416 Ontario Ltd. |
Ontario (Canada) | I | CAD | 1,210 | 100.0% |
| Sackville Hearing Centre Limited | Nova Scotia (Canada) | I | CAD | 1,020 | 100.0% |
| Hometown Hearing Centre Inc | Bancroft (Canada) | I | CAD | 400 | 100.0% |
| GAES S.A. | Santiago de Chile (Chile) |
I | CLP | 1,901,686,034 | 100.0% |
| GAES Servicios Corporativo de Latinoamerica Spa |
Sanhtiago de Chile (Chile) |
I | CLP | 10,000,000 | 100.0% |
| Audiosonic Chile S.A. | Santiago de Chile (Chile) |
I | CLP | 1,000,000 | 99.0% |
| GAES S.A. | Buenos Aires (Argentina) |
I | ARS | 120,542,331 | 100.0% |
| GAES Colombia SAS | Bogotà (Colombia) | I | COP | 22,000,000,000 | 100.0% |
| Audiovital S.A. | Quito (Ecuador) | I | USD | 430,337 | 100.0% |
| Centros Auditivos GAES Mexico sa de cv |
Ciudad de México (Mexico) |
I | MXN | 276,477,133 | 100.0% |
| Compañía de Audiologia y Servicios Medicos sa de cv |
Aguascalientes (Mexico) |
I | MXN | 43,306,212 | 100.0% |
| GAES Panama S.A. | Panama (Panama) | I | PAB | 510,000 | 100.0% |
| Amplifon Australia Holding Pty Ltd | Sydney (Australia) | D | AUD | 392,000,000 | 100.0% |
| National Hearing Centres Pty Ltd | Sydney (Australia) | I | AUD | 100 | 100.0% |
| National Hearing Centres Unit Trust | Sydney (Australia) | I | AUD | - | 100.0% |
| Attune Hearing Pty Ltd | Brisbane (Australia) | D | AUD | 14,771,093 | 100.0% |
| Attune Workplace Hearing Pty Ltd | Brisbane (Australia) | I | AUD | 1 | 100.0% |
| Ear Deals Pty Ltd | Brisbane (Australia) | I | AUD | 300,000 | 100.0% |
| Otohub Unit Trust (in liquidazione) | Brisbane (Australia) | D | AUD | - | 100.0% |
| Otohub Australasia Pty Ltd | Brisbane (Australia) | D | AUD | 10 | 100.0% |
| Bay Audio Pty Ltd | Sydney (Australia) | D | AUD | 10,000 | 100.0% |
| Amplifon Asia Pacific Pte Limited | Singapore (Singapore) | I | SGD | 1,000,000 | 100.0% |
| Amplifon NZ Ltd | Takapuna (New Zealand) |
I | NZD | 130,411,317 | 100.0% |
| Bay Audiology Ltd | Takapuna (New Zealand) |
I | NZD | - | 100.0% |
| Dilworth Hearing Ltd | Auckland (New Zealand) |
I | NZD | - | 100.0% |
| Auckland Hearing Ltd | Auckland (New Zealand) |
I | NZD | - | 100.0% |
| Amplifon India Pvt Ltd | Gurgaon (India) | I | INR | 2,050,000,000 | 100.0% |

| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital | % held as at 09/30/2023 |
|---|---|---|---|---|---|
| Beijing Amplifon Hearing Technology Center Co. Ltd |
Běijīng (China) | D | CNY | 2,143,685 | 100.0% |
| Tianjin Amplifon Hearing Technology Co. Ltd |
Tianjin (China) | I | CNY | 3,500,000 | 100.0% |
| Shijiazhuang Amplifon Hearing Technology Co. Ltd |
Shijiazhuang (China) | I | CNY | 100,000 | 100.0% |
| Amplifon (China) Investment Co. Ltd | Shanghai (China) | D | CNY | 177,800,000 | 100.0% |
| Hangzhou Amplifon Hearing Aid Co. Ltd (**) |
Hangzhou (China) | D | CNY | 11,000,000 | 60.0% |
| Zhengzhou Yuanjin Hearing Technology Co Ltd. (**) |
Zhengzhou (China) | I | CNY | 100,000 | 60.0% |
| Wuhan Amplifon Hearing Aids Co. Ltd |
Wuhan (China) | I | CNY | 16,250,000 | 100.0% |
| Shanghai Amplifon Hearing Technology Co. Ltd |
Shanghai (China) | I | CNY | 100,000 | 100.0% |
| Nanjing Amplifon Hearing Aid Co. Ltd | Nanjing (China) | I | CNY | 100,000 | 100.0% |
| Shanxi Tingdaoai Hearing Technology Co.Ltd |
Taiyuan (China) | I | CNY | 30,000,000 | 100.0% |
| Henan Shengjia Hearing Aids Co., Ltd. (**) |
Luoyang (China) | I | CNY | 1,000,000 | 60.0% |
| Fuzhou Tingan Medical Device Co. Ltd |
Fuzhou (China) | I | CNY | 20,000,000 | 100.0% |
| Chongqing Amplifon Hearing Aids Co. Ltd. |
Chongqing (China) | I | CNY | - | 100.0% |
(*) Medtechnica Ortophone Ltd, despite being 90% owned by Amplifon, is consolidated at 100% without exposure of non-controlling interests due to the put-call option exercisable from 2019 and related to the purchase of the remaining 10%.
(**) Hangzhou Amplifon Hearing Aid Co.. Ltd. And its subsidiaries Zhengzhou Yuanjin Hearing Technology Co. Ltd and Henan Shengjia Hearing Aids Co., Ltd. (together Soundbridge) and Henan Shengjia Hearing Aids Co., Ltd. are consolidated using the full consolidation method, with a control of the group of 60% because of the direct ownership of 51% and a put-call option for an additional 9%.
Companies valued using the equity method:
| Company name | Head office | Direct/Indirect ownership |
Currency | Share Capital |
% held as at 09/30/2023 |
|---|---|---|---|---|---|
| Comfoor BV (*) | Doesburg (The Netherlands) |
I | EUR | 18,000 | 50.0% |
| Comfoor GmbH (*) | Emmerich am Rhein (Germany) |
I | EUR | 25,000 | 50.0% |
| Ruti Levinson Institute Ltd (**) | Ramat HaSharon (Israel) |
I | ILS | 105 | 16.0% |
| Afik - Test Diagnosis & Hearing Aids Ltd (**) |
Jerusalem (Israel) | I | ILS | 100 | 16.0% |
| Lakeside Specialist Centre Ltd (**) | Mairangi Bay (New Zealand) |
I | NZD | - | 50.0% |
(*) Joint Venture
(**) Related companies

Declaration of the Executive Responsible for Corporate Accounting Information pursuant to Article 154-bis of Legislative Decree 58/1998 (Consolidated finance act)
We, the undersigned, Enrico Vita, Chief Executive Officer and Gabriele Galli, Executive Responsible for Corporate Accounting Information for Amplifon S.p.A., taking into account the provisions of article § 154-bis, paragraphs 3 and 4 of Law no. 58/98, certify:
- the adequacy, by reference to the characteristics of the business and
- the effective application of the administrative and accounting procedures for the preparation of the condensed interim consolidated financial statements during the period 1 January – 30 September 2023.
We also certify that the condensed interim consolidated financial statements at 30 September 2023:
- have been prepared in accordance with the international accounting standards recognized in the European Union under the EC regulation no. 1606/2002 of the European Parliament and of the Council of 19 July 2002;
- correspond to the underlying accounting entries and records;
- provides a true and fair view of the performance and financial position of the issuer and of all of the companies included in the consolidation area.
The report on operations includes a reliable operating and financial review of the Company and all of the companies included in the consolidation area.
Milan, October 30th, 2023
CEO Executive Responsible for Corporate Accounting Information
Enrico Vita Gabriele Galli